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CHAPTER I 
INTRODUCTION AND REVIEW OF THE LITERATVRE 
Of all diseases 1n cattle, 40% to 80% have been reported to 
involve the respiratory system (Lillie, 1974). The econom1c importance 
of respiratory diseases to the beef cattle industry, particularly 
feedlot operations is extremely significant. Losses due to fatalities, 
loss of conditioning, inefficient feed conversion, and expensive 
treatments run into the millions of dollars each year (Rehmtulla and 
Thomson, 1981). The major cause of these losses in feedlot cattle is 
the shipping fever complex. In a feedlot survey, 75% of the clinical 
diagnoses and 64% of the necropsy diagnoses were respiratory tract 
diseases. Of the fatalities from respiratory disease, 75% were due 
to shipping fever pneumonia (Jensen et al., 1976). The exact nature 
and etiology of shipping fever in cattle have long been sources of 
debate and confusion (Lillie, 1974; Rehmtulla and Thomson, 1981; 
Thomson, 1980b) . Though the term shipping fever encompasses numerous 
etiological factors, such as stress and viral infections, it has also 
come to be used to refer specifically "to the disease pneumonic 
pasteurellosis. 
Pathogenesis 
The pathogenesis of pneumonic pasteurellosis is a complex, 
multifactorial process. Management practices, stress, multiple 
1 
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infectious agents, local pulmonary defense mechanisms, and immunological 
responses combine to produce the 'disease syndrome. The precise role 
and significance of each of these factors remain poorly understood. 
The one common feature shared by most cases of shipping fever is the 
involvement of Pasteurella haemolytica. The importance of this 
organism in the disease has become well established (Carter, 1964; Hamdy 
and Trapp, 1967; Thomson et al., 1969), and it is generally regarded 
as the ultimate cause of the clinical and pathological characteristics 
commonly associated with shipping fever. 
Pasteurella haemolytica is part of the normal, basal microflora 
present in the bovine nasal cavity (Magwood et al., 1969). In normal 
cattle, cultures of nasal swabs are frequently negative for the organism 
(Hoerlein et al., 1961). However, if several areas of the nasal mucosa 
are cultured, P. haemolytica can often be isolated from animals which 
had been negative on single nasal swabs (Pass et al., 1971). Normally, 
the organisms are present in small numbers and localized to the upper 
respiratory tract, especially the nasopharyngeal region and the 
tonsillar crypts. They can remain there for long periods of time 
without producing any signs of clinical illness (Babiuk and Acres, 
1984). Transient flucuations in both the type and quantity of nasal 
bacterial flora occur. P. haemolytica has been found to be capable 
of dominating the nasal flora for periods of several days, at which 
time colonization and active shedding of the organism are possible 
(Magwood et al., 1969). Rapid proliferation of P. haemolytica in 
the nasal cavity also occurs in cattle that have been recently 
congregated and shipped (Thomson, 1980a,b; Thomson et al., 1969; Frank 
and Smith, 1983). The presence of greater numbers of organisms in the 
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nasal cavity increase the chance of aerosolization and deposition of 
organisms into deeper portions of the airways or into the lungs 
themselves (Thomson et al., 1969; Grey and Thomson, 1971). In some 
studies, the frequency of isolation of P. haemolytica from the nasal 
cavity was much greater in sick cattle than in normal cattle (Thomson 
et ai., 1975; Hoerlein et al., 1961). In other instances, however, 
no significant difference in isolation frequency could be detected 
between healthy and diseased calves (Frank and Smith, 1983). 
A potentially important factor that determines the incidence of 
disease in calves with increased numbers of intranasal P. haemolytica 
~s the ability of the organism to adhere and to colonize on the 
respiratory mucosa. Bacterial adherence to host tissues appears to 
be a primary step in the colonization and subsequent infection of 
mucosal surfaces of the gastrointestinal, genitourinary, and respiratory 
tracts (Beachey, 1981; Ramphal et al., 1980). Bacterial adherence 
depends upon the presence of both specific receptors on mucosal 
epithelium as well as surface structures on bacteria which have adhesive 
characteristics (adhesins) (Beachey, 1981). Certain strains of P. 
multocida Type A will adhere to rabbit pharyngeal mucosa while other 
types will not. Adherent strains, but not non-adherent types, possess 
fimbriae which acted as adhesins. Fimbriae were able to attach to 
N-acetyl glucosamine-containing receptors on the epithelium and promote 
colonization both in vivo and in vitro (Glorioso et al., 1982). 
In humans, a high degree of specificity is involved in the attachment 
of certain types of bacteria to nasal mucosa. The adherence of 
Staphylococcus aureus was found to be significantly higher ~n people 
who were carriers of the organism as normal flora compared to people 
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who were non-carriers. The enhanced staphylococcal adherence of 
carr~ers may be due to a difference in either the surface 
characteristics of the mucosal epithelium or an altered local mucosal 
environment (Aly et al., 1977). 
effect staphylococcal adherence. 
Bacterial factors do not appear to 
Adherence and colonization of Gram 
negative bacteria on resplratory mucosa is enhanced in humans who are 
ill (Johanson et al., 1980). Viral infection both in vivo and in 
vitro and mechanical mucosal damage also result in increased bacterial 
adherence when compared to non-infected or undamaged mucosa (Sanford 
et al., 1978; Ramphal et al., 1980). The mechanism of this enhanced 
adherence may be related to an alteration of the mucosal surfaces which 
promotes adherence or a reduction in fibronectin levels resulting from 
destruction of fibronectin-producing mucosa (Aly et al., 1977; Babiuk 
and Acres, 1984). Enhanced adherence and subsequent repl ic·ation can 
result in microcolonies which increase the potential of exposure of 
the lower respiratory tract to bacteria. 
described for P. haemolytica. 
Adhesion has not been 
Under normal conditions, bacteria gaining access to the respiratory 
tract are quickly cleared. In normal calves, 75% of inhaled P. 
haemolytica were cleared by 2 hours, with 92% clearance being 
accomplished by 8 hours (Lillie and Thomson, 1972). Mechanisms 
responsible for clearance include the cough reflex, physical filtration 
of the bacteria in the nasopharyngeal region, the upper respiratory 
mucociliary apparatus, the alveolar macrophage system, and cellular 
and humoral defense mechanisms (Thomson, 1980b). Aerosols containing 
large numbers of P. haemolytica have occasionally been successful 
in causing clinical and path'ologic evidence of disease (Duncan and 
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Thomson, 197 0; Thomson, 1980 a) . In most cases, however, attempts to 
cause clinical infection with P. haemolytica alone have been largely 
unsuccessful and resulted in no change or only mild transient fever 
and illness (Thomson, 1980b; Baldwin et al., 1967; Jericho and Langford, 
197 8) . In most situations, additional factors which either inhibit 
some segment of the pulmonary defense system, or otherwise alter the 
host response to the bacteria are necessary for significant disease 
to occur (Thomson, 1980a). Many of these predisposing factors are 
related to management or physical conditions and are best categorized 
as stress. Other factors include either the direct or indirect results 
of concurrent infection with another organism, most often a v~rus. 
Stress factors can·encompass a wide variety of conditions. These 
include transport, overcrowding, food and water deprivation, wet or 
cold weather, and overzealous processing of cattle at the feedlot. 
Decreased pulmonary clearance of bacteria resulted from exposure of 
mice to cold, wet conditions (Green and Kass, 1965), or physical stress 
~n rabbits (Lockard et al., 1973). Administration of hydrocortisone 
to calves caused reduced pulmonary clearance. This effect, however, 
was suspected to be mediated by an induced pulmonary edema rather than 
any immunosuppressive effects (Gilka et al., 1974). Cold stress, as 
well as transportation and handling have been found to increase serum 
cortisol levels (Filion et al., 1984; Kelley, 1984). High cortisol 
levels can possibly act to increase susceptibility of calves to 
pneumonic pasteurellosis by reducing immune responsiveness and leukocyte 
function, as well as by enhancing replication of any predisposing virus 
which may be present in the upper respiratory tract (Filion et al., 
1984). Cold stress caused an initial decrease in serum IgM and enhanced 
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cell-mediated immune functions (Kelley, 1984). In contrast, 
transportation and handling caused decreased lymphocyte blastogenic 
response to phytohemagglutinin (Filion et al., 1984). These results 
indicate the multiple and complex factors involved in the response of 
calves to various types of stress. 
A large percentage of all bacterial pneumonias ~n the bovine are 
estimated to be secondary to a viral infection or some other form of 
debility (Lillie, 1974). Viral predisposition of the lung to bacterial 
infection could be caused by either direct tissue damage or by 
inhibition of pulmonary defense mechanisms. Many viruses replicate 
in the ciliated and nonciliated epithelium of the upper respiratory 
tract. Degeneration and desquamation of these cells creates regions 
with enhanced susceptibility to bacterial adherence and colonization. 
In addition, normal functioning of the mucociliary apparatus is impaired 
(Lopez et al., 1976). Certain viruses can also destroy type II 
pneumocytes with a resultant reduction in intraalveolar surfactant 
production (Jakab, 1984). Surfactant has been shown to enhance 
phagocytosis of certaii bacteria by alveolar macrophages (LaForce, 
1976; Coonrod and Yoneda, 1983). In addition, it contains substances, 
probably lysophospholipids, which have direct lytic effects on certain 
bacteria (Coonrod and Yoneda, 1983). Pulmonary edema, commonly produced 
by viral respiratory infections involving lung parenchyma, consistently 
results in prolonged pulmonary clearance times of bacteria (Gilka et 
al., 1974; Lopez et al., 1976). 
Viral infections may play a vital role in the pathogenesis of 
shipping fever. Exposure to bovine herpesvirus-! or parainfluenza 
virus-3 followed by aerosol exposure to P. haemolytica several days 
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later will consistently produce lesions resembling shipping fever 
(Jericho and Langford, 1978; Stockdale et al., 1979a,b; Thomson, 1980a; 
Baldwin et al., 1967; Jakab, 1974). This synergism appears to be due 
to the ability of viruses to inhibit the clearance of Pasteurella sp. 
from the lung (Jakab, 1974; Lopez et al., 1976; Yates, 1982). Increased 
clearance time does not seem to be associated with decreased mucociliary 
apparatus function, but rather is caused by a transient suppression 
of pulmonary bactericidal activity caused by dysfunction of the alveolar 
macrophage system (Jakab, 1974; Couch, 1981). 
Many viral-induced defects in macrophage function have been 
described. Parainfluenza virus inhibited. both non-specific and Fe 
receptor-mediated phagocytosis by mouse macrophages (Jakab and Warr, 
1981; Warr and Jakab, 1979). Ingestion and intracellular killing of 
Staphylococci or Candida sp. by influenza virus infected macrophages 
were also suppressed (Warr and Jakab, 1979; Warshauer et al., 1977; 
Jakab and Green, 1976). The defect in intracellular killing appears 
to be partially due to inhibition of phagosome-lysosome fusion (Jakab 
et al., 1980; Hesse and Toth, 1983). In addition, viral infection 
inhibits chemotaxis and aggregation of macrophages and monocytes 
(Kleinerman et al., 1974, 1975, 1976). Neutrophils also have defects 
in chemotaxis, phagocytosis, chemiluminescence, and bactericidal 
activities when exposed to influenza virus (Abramson et al., 1981; 
Larson and Blades, 1976; Sawyer, 1969). Maximum suppression of the 
alveolar macrophage system appears to occur 1 week following the initial 
viral infection (Abramson et al., 1981; Jakab, 1974; Jakab et al., 
1 9 8 0 ; Lopez e t a 1 . , 1 9 7 6 ) . This period is associated with rapidly 
declining viral titers, an increased expression of local antiviral 
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immune responses, and increased susceptibility of the lungs to a 
secondary bacterial infection (Lop_ez et al., 1976; Wells et al., 1981; 
Jakab, 1982). The time frame for maximum suppression suggests that 
alveolar macrophage dysfunction may be secondary to the humoral and 
cell-mediated antiviral immune responses of the host rather than due 
to a direct effect of the virus (Jakab, 1982). This suggestion is 
supported by studies which showed that viral infected immunodeficient 
and immunosuppressed mice developed less cellular infiltration and 
milder histopathological lung lesions than normal, immunocompetent mice 
(Wells et al., 1981; Hurd and Heath, 1975). In addition, fatalities 
in immunosuppressed mice occurred later than in normal mice and were 
due to extrapulmonary dissemination of the virus rather than pulmonary 
infections as were seen in the normal mice (Hurd and Heath, 1975). 
Possible explanations for this secondary viral inhibition of macrophages 
include the generation of cytotoxic immune responses against viral-
infected macrophages and a decrease in Fe receptor-mediated phagocytosis 
due to increased levels of immune complexes (Jakab, 1982). 
Once colonies of P. haemolytica have become established 1n the 
pulmonary parenchyma, many characteristics of the bacteria itself become 
prominent factors in pathogenesis. Early logarithmic-phase growths 
of P. haemolytica are encapsulated (Corstvet et al., 1982). The 
presence of capsules has been shown to enhance the pathogenicity of 
a variety of bacterial diseases (Smith, 1977; Densen and ~andell, 
1980). Encapsulation can function in several ways to make the bacteria 
more resistant to host defense mechanisms. Certain components of the 
capsule may be able to enhance bacterial adherence to respiratory mucosa 
(Smith, 1977; Glorioso et al., 19S2). An important function for 
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bacterial capsules ~s to prevent phagocytosis. The mechanism for this 
antiphagocytic effect ~s unclear, but may be related to alterations 
in cell membrane-bacterial interactions or to the inhibition of binding 
of opsonins to the surface of the encapsulated bacteria (Densen and 
Mandell, 1980). The presence of a capsule may be the reason for the 
low rate of phagocytosis of P. haemolytica by bovine alveolar 
macrophages in vitro in the absence of opsonins (Maheswaran et al., 
1980). Immunization with extracts of capular material from P. 
haemolytica and P. multocida have produced variable degrees of 
protection in mice, sheep, and cattle (Mukkur, 1977; Tadayon and 
Lauerman, 1981; Gilmour et al., 1979; Nagy and Penn, 1976; Yates et 
al., 1983). These studies suggest a possible role for capsular material 
~n the pathogenesis of shipping fever. Encapsulation of ~ 
haemolytica does appear to enhance resistance against the bactericidal 
activity of bovine serum (Gentry, 1984). Antiphagocytic effects or 
other depression of pulmonary defense mechanisms by P. haemolytica 
capsular material, however, have not been firmly established. 
Endotoxins are part of the outer membrane of Gram negative bacteria 
and can play important roles in many bacterial infections (Cluff, 
1971). These are complex lipopolysaccharides released from dying 
bacteria. Lipopolysaccharides consist of a core polysaccharide, 
polysaccharide side chains, and a toxic lipid A portion. Endotoxins 
cause a transient decrease in resistance to bacterial infections due 
to a wide variety of mechanisms. Included among these are consumption 
of complement components, transient depression of reticuloendothelial 
function, decreased leukocyte chemotaxis, shifts in distribution of 
granulocytes, variation of blood coagulability, alterations of cellular 
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metabolism, fever, and vasoactive effects. Well defined changes seem 
to occur in the lungs due to endotoxin exposure (Snell, 1966). An 
aerosol of Eschericia coli endotoxin was rapidly absorbed causing 
an immediate transient leukopenia followed in 2 hours by leukocytosis 
and fever. By 24 hours, focal capillary hemorrhage, alveolar edema, 
and alveolar infiltrates of macrophages, neutrophils, and eosinophils 
were present. Proliferation of alveolar macrophages associated with 
a reduction in edema occurred by 48 hours. Aerosols of P. mul tocida 
have been found to produce similar pulmonary edema and capillary 
hemorrhage (Rhoades et al., 1967). The endotoxin of P. haemolytica 
demonstrates typical properties of endotoxins and exerts its major 
physiologic effect in the bovine by increasing pulmonary vascular 
resistance (Keiss et al., 1964). It has been hypothesized that many 
of the clinical and pathological alterations associated with pneumonic 
pasteurellosis may be attributed to endotoxin (Lillie, 1974; Keiss et 
al., 1964; Jensen et al., 1976). 
An exotoxin is produced by logarithmic-phase P. haemolytica 
(Benson et al., 1978). This toxin (cytotoxin), can interfere with the 
function of bovine leukocytes (Benson et al., 1978; Markham and Wil-kie, 
1980; "Berggren et al., 1981). Inhibition of phagocytosis when low 
numbers of organisms are exposed to bovine alveolar macrophages or 
neutrophils has been attributed to the toxin (Benson et al., 1973; 
Markham and Wilkie, 1980; Walker et al., 1984; Maheswaran et al., 
1980). At higher bacterial concentrations or with bacteria-free 
supernatants, cytotoxin is toxic to bovine alveloar macrophages, 
neutrophil s, 1 ymphoc ytes, and monocytes (Benson et al., 1978; Markham 
and Wilkie, 1980; Shewen and Wilkie, 1982; Berggren et al., 1981; 
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Kaehler et al., 1981). Cytotoxicity occurs rapidly in vitro and 
is highly specific for bovine or ovine leukocytes (Shewen and Wilkie, 
1982). The exotoxin has been partially purified and characterized, 
but the range of its biological activity, biochemical parameters, and 
mechanism of action are still unclear (Baluyut et al., 1981; Himmel 
et al., 1982). 
Studies on the cytotoxin neutralizing capabilities of bovine sera 
have demonstrated that cattle dying of fibrinous pneumonia have lower 
anticytotoxin activity than non-pneumonic cattle (Shewen and Wilkie, 
1983; Cho et al., 1984; Gentry et al., 1985). Anticytotoxin activity 
has been demonstrated to be antibody in nature and is present 1n nasal 
secretions and lung washings as well as sera (Cho et al., 1984). These 
findings implicate cytotoxin as a possible factor involved in the 
pathogenesis of pneumonic pasteurellosis. 
Several serotypes of P. haemolytica possess neuraminidase 
activity (Frank and Tabatabai, 1981; Otulakowski et al., 1983). 
Neuraminidase production by several species of bacteria has been 
associated with virulence (Milligan et al., 1978; Ray, 1977; Smith, 
1977). In one study, P. haemolytica serotype 1 had higher 
neuraminidase activity than P. haemolytica serotype 2. This suggested 
a possible relationship between the higher neuraminidase levels and 
the greater incidence of disease due to serotype 1 (Frank and Tabatabai, 
1981). It has been suggested that neuraminidase may play a role 1n 
disease by altering leukocyte membranes with a resultant unmasking of 
receptor sites for cytotoxin (Otulakowski et al., 1983). Overall, 
however, neuraminidase probably plays a minor role, if any, in pneumon1c 
pasteurellosis. 
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Protease activity has also been detected ~n supernatants from 
several P. haemolytica serotypes, including serotype 1. The enzyme 
was characterized as a probable metal-dependent neutral protease with 
specificity for sialoglycoproteins. Possible virulence enhancing 
mechanisms proposed for this protease include membrane damage with 
resultant enhanced cytotoxin susceptibility, unmasking of receptor sites 
for cytotoxin in a similar manner to that proposed for neuraminidase, 
or cleavage of cytotoxin into active components if it is secreted as 
a prototoxin (Otulakowski et al., 1983). 
Besides the possible direct effects of P. haemolytica or its 
products on producing the lesions of pneumonic pasteurellosis, the host 
immune response to these bacterial antigens may also provide a 
significant contribution to the pathogenesis of disease. Numerous 
components of the inflammatory response are capable of initiating 
pulmonary damage. Alveolar macrophages can play an active role in many 
forms of pulmonary injury by both their phagocytic and secretory 
functions (Nathan et al., 1980). Activated and stimulated macrophages 
can secrete hydrolytic enzymes and proteases in response to lymphokines, 
~mmune complexes, foreign material such as bacteria, endotoxin, 
complement, and numerous others (Slauson, 1982). The major leukocytic 
enzymes involved ~n pulmonary damage are the neutral proteases 
collagenase, elastase, and cathepsin G, as well as the acid protease 
cathepsin D. These enzymes produce damage by degrading connective 
tissue substrates in vessel walls, perivascular tissues, and 
interalveolar septa (Davies and Bonney, 1980). Phagocytic and secretory 
functions of macrophages are enhanced as the degree of their activation 
increases and has been demonstrated by a positive correlation between 
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macrophage activation and th~ extent of histological lesions in 
hypersensitivity pneumonitis (Stankus et al., 1978). Macrophages can 
affect other aspects of inflammation which have potential to cause 
pulmonary injury by their secretion of complement components, endogenous 
pyrogens, reactive oxygen metabolites, bioactive lipids (prostaglandins 
and leukotrienes), and regulatory monokines (Nathan et al., 1980; 
Slauson, 1982). This ability to secrete damaging enzymes and to 
interact with other components of the inflammatory response give the 
alveolar macrophage the ability to not only defend the lung but also 
to damage it. 
Neutrophils can also cause significant pulmonary damage by their 
response to infection. During influx to the lungs, neutrophils 
aggregate in pulmonary capillaries and subsequently migrate into the 
interalveolar septa. Neutrophil sequestration ~n vessels has been shown 
to cause endothelial damage both ~n vivo and in vitro 
(Hammerschmidt, 1983). Like macrophages, neutrophils have a potent 
array of lysosomal enzymes which can be released extracellularly to 
cause tissue damage (Baggiolini, 1980). Enzyme release can occur either 
by death and lysis of the leukocyte, leakage of enzymes due to premature 
phagosome-lysosome fusion, or release of enzymes against a 
non-phagocytosible object (Slauson, 1982). In addition, toxic oxygen 
free radicals produced by neutrophils, and to a lesser extent by 
macrophages during phagocytosis, can diffuse extracellularly and damage 
pulmonary tissues as well as the leukocytes themselves (Fridovich, 
1978). Neutrophil enzyme products can also modify other aspects of 
inflammation by liberation of chemotactic factors, kinin generating 
activity, stimulation of B-and T-lymphocytes, complement cleavage, 
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and interaction with the fibrinolytic system (Slauson, 1982). 
The lung contains many vasoactive substances including histamine, 
serotonin, kinins, and prostaglandins. All of these are liberated 
during an inflammatory response and can increase vascular permeability 
(Slauson, 1982). Permeability changes can cause leakage of edema fluid, 
fibrinogen, and other plasma proteins from the vessels into alveolar 
spaces. Leakage of these substances, particularly fibrinogen, appears 
to be an important mechanism in the development of pneumonic 
pasteurellosis. Fibrinogen can polymerize to form fibrin which fills 
alveoli, plugs airways, and provides a medium which enha~ces bacterial 
growth and inhibits clearance. Fibrinogen can also inactivate 
surfactant causing an increase in surface tension and greater tendency 
for alveolar collapse. Bactericidal activities of surfactant are also 
reduced by the presence of fibrinogen (Slauson, 1982). 
All of the proteins of the complement system are present 1n the 
lung and can be activated by a wide variety of immunologic and 
non-immunologic stimuli. Consequences of complement activation include 
generation of anaphylatoxins and chemotaxins, lytic reactions, and 
opsonization of antigens. Complement has been shown to cause 
sequestration of neutrophils in terminal pulmonary vasculature (Henson 
et al., 1979), and produces variable degrees of pulmonary inflammation 
following instillation of C3 or CS fragments into the lung (Larsen et 
al., 1980; Henson et al., 1979). These reactions and the association 
of complement with leukocytes and bacteria during inflammation can 
result in substantial pulmonary injury. 
The effect of the humoral 1mmune response to P. haemolytica on 
the pathogenesis of pneumonia is variable. As previously mentioned, 
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cytotoxin neutralizing antibody titers appear to correlate positively 
with resistance to disease (Shewen and Wilkie, 1983; Cho et al., 1983; 
Gentry et al., 1985), while anticapsular antibody effects are variable 
(Tadayon and Lauerman, 1981; Yates et al., 1983; Matsumoto et al., 
1984). In some studies, a strong antibody response against somatic 
antigens seems to enhance the disease (Bennett, 1982; Friend et al., 
1977; Wilkie et al., 1980). This adverse effect is incompletely 
understood, but may be related to increased opsonization and 
phagocytosis of bacteria with a resultant magnification of cytotoxic 
effects on alveolar macrophages (Wilkie et al., 1980). 
A well characterized cell-mediated immune response occurs against 
some of the v~ruses which commpnly predispose to pneumonic 
pasteurellosis (Campos et al., 1982; Davies and Carmichael, 1973; Gerber 
et al., 1978). The cell-mediated response toP. haemolytica, however, 
has not been adequately evaluated. The possible significance of 
cell-mediated immunity in pneumonic pasteurellosis has been occasionally 
mentioned (Markham and Wilkie, 1980; Yates et al., 1983; Confer et al., 
1984), but association of this immunity with resistance to the disease 
has not been shown. 
Gross and Microscopic Lesions 
Failure to develop adequate resistance to the various factors 
involved in the pathogenesis of shipping fever results ~n an acute 
fibrinous pleuropneumonia. Clinically, there is fever, anorexia, 
depression, nasal discharge, and bronchial and pleuritic sounds in the 
anteroventral portion of the thorax (Jensen et al., 1976). These signs 
can be present over a period of several days and generally terminate 
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fatally if left untreated. In cases caused by P. haemolytica, there 
are bilaterally extensive sheets and strands of fibrin present on the 
visceral and parietal pleura (Schiefer et al., 1978). Fibrinous 
pericarditis and variable amounts of yellow, fibrinous thoracic fluid 
are sometimes present. The anteroventral two-thirds of the lung are 
usually pneumonic and appear enlarged, firm, and heavy. The cardiac 
lobe is usually the most severely affected and can be 10 times its 
normal weight due to filling with fluid and exudate. Lobules vary in 
color from red to gray to red-black and are separated by widened 
interlobular septa which contain edema, fibrin, and air bubbles. 
Interlobular lymphatics are sometimes dilated and may contain fibrin 
clots. On cross section, lobules are firm and airless. Occasionally, 
regions of infarction and coagulative necrosis characterized by pale 
brown to black tissue surrounded by a gray zone are present. Thrombi 
can sometimes be detected in associated vasculature. Bronchioles and 
affected bronchi have reddened mucosa and are partly filled with blood, 
fibrin, mucus, and pus (Jensen et al., 1976; Friend et al., 1977; 
Rehmtulla and Thomson, 1981 Scheifer et al., 1978). 
Histologically, subpleural connective tissue and interlobular septa 
are widened and often contain dilated, thrombosed lymphatics. 
Approximately 98% of the thickened septa contain fibrin, 83% contain 
edema fluid, and 56% are emphysematous (Graham, 1953). Bronchi and 
bronchioles frequently contain variable amounts of fibrin, mucus, 
neutrophils, cellular debris, erythrocytes, and macrophages. Mucosal 
epithelium is sometimes desquamated and contains inflammatory cells, 
but in most cases the mucosa is intact and there is little evidence 
of bronchitis or bronchiolitis (Scheifer et al., 1978). In recently 
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infected lobules, alveoli are filled with fibrin. In the well-developed 
lesion, alveoli contain fibrin, neutrophils, alveolar macrophages, and 
scattered colonies of bacteria. Macrophages are sometimes large, round, 
and contain pale eosinophilic cytoplasm, but in many cases they are 
dark and fusiform. In some areas, these fusiform macrophages dominate 
the lesion and fill many alveoli. Variable amounts of hemorrhage are 
present in alveoli. Pulmonary veins and capillaries are frequently 
thrombosed or contain immature clots. Thrombosed ve~ns are often 
surrounded by fusiform macrophages and sometimes are associated with 
regions of coagulative necrosis. Necrosis is seen occasionally in 
association with thrombosed lymphatic vessels as well. Necrotic areas 
frequently extend across interlobular septa and are surrounded by a 
variable sized zone containing numerous neutrophils, fusiform 
macrophages, and bacteria (Jensen et al., 1976; Scheifer et al., 1978). 
In experimentally induced disease, lesions at 18 hours consist 
primarily of variable degrees of atelectasis with alveoli containing 
fibrin, neutrophils, and macrophages. By 3 days, the lesion is fully 
developed and compatible with the changes previously described. In 
animals surviving the acute phase of the disease, organization of fibrin 
begins by 7 days. The lesion at this point is characterized by early 
obliterative bronchiolitis, lymphoid hyperplasia around airways, 
granulation of necrotic tissue, and occasionally abscess formation 
(Friend et al., 1977). 
In contrast to the fibrinous pleuropneumonia commonly associated 
with P. haemolytica, P. multocida often causes a bronchopneumonia 
(Scheifer et al., 1978). The lesion is characterized by airways which 
are filled with purulent material, fairly uniform dark red lobules, 
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and a peribronchiolar distribution of alveoli containing neutrophils 
and macrophages. Fibrin is not an important component of the lesion. 
Interlobular septal lymphatic thrombosis and necrosis are not commonly 
present (Scheifer et al., 1978). 
Based upon the nature of the pulmonary lesion caused by~ 
haemolytica, endotoxin has been considered to be a major pathogenetic 
mechanism of tissue damage once colonization by bacteria has occurred 
(Jensen et al., 1976). Endotoxin has been blamed for the clotting and 
thrombosis of lymphatics, veins, and capillaries and the resulting 
hemorrhagic infarction and necrosLs. Endotoxin can cause increased 
vascular permeability with large amounts of exuded fibrin which are 
characteristic of the disease. The role of cytotoxin, capsular 
antigens, viral infections, the host immune response, or other factors 
are difficult to determine on the basis of morphological evaluation 
of the in vivo lesion. Fatalities are generally attributed to 
hypoxia, endotoxemia, pulmonary necrosis, shock, and heart failure 
(Jensen et al., 1976). 
Vaccination 
Because of numerous factors involved Ln the etiology and 
pathogenesis of pneumonic pasteurellosis, prevention of the disease 
has proven difficult. Factors such as stress and exposure to various 
infectious agents are difficult to control. The major emphasis in 
management of the disease has been to devise methods to enhance the 
hosts 0 immunological resistance to commonly incriminated infectious 
agents. Several experimental approaches to this problem have been 
taken. These are to vaccinate cattle with P. haemolytica, P. 
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multocida, or components of these bacteria, to vaccinate against the 
viruses which commonly predispose to pneumonic pasteurellosis, or to 
use the bacterial and viral vaccLnes in combination (Collier, 1968; 
Anonymous, 1968; Engelbrecht, 1968). 
Pagteurellae are frequently considered to be the sole cause of 
the advanced clinical signs and lesions of shipping fever, while other 
factors act only to predispose the calf to this bacterial infection 
(Collier, 1968; Lillie, 1974). Uue to the apparent central role of 
Pasteurellae in pneumonic pasteurellosis, much effort has been devoted 
to examination of various P. haemolytica and P. multocida 
bacterins. The use of bacterins to prevent the disease, however, has 
proven largely ineffective (Engelbrecht, 1968; Hoerlein, 1957). The 
questionable efficacy of bacterins may be due to failure to incorporate 
the correct antigenic serotypes into the vaccines, too few numbers of 
bacteria, inadequate adjuvants, or the use of the wrong growth phase 
of the organisms (Collier, 1968; Anonymous, 1968). Early reports on 
the use of bacterins were mainly from uncontrolled field trials and 
the results were uninterpretable. A bivalent P. haemolytica/~ 
multocida bacterin was used with apparent success (Carter, 1957). 
In later studies, the use of hemorrhagic septicemia bacterins (~ 
multocida) and antisera as preventatives seemed to result in some 
reduction in the incidence of shipping fever, but management practices 
seemed to have a greater influence than either of these bacterial 
products (Schipper et al., 1962). Palotay et al. (1963) evaluated 
several bacterins in cattle. Agents used for vaccination included 
commercially available hemorrhagic septicemia bacterin, a formalinized 
vaccine produced by injection of P. haemolytica into the yolk sac 
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of chick embryos, and a bivalent P. haemolytica/P. multocida 
bacterin. Vaccination with any of these agents prior to shipment was 
reported to result in a significant reduction in the incidence of 
respiratory disease when compared to unvaccinated controls. It was 
noted, however, that there was still a fairly high incidence of 
respiratory disease even in vaccinated animals, indicating that factors 
other than the bacteria may be involved in shipping fever. Contrasting 
results have been obtained in more recent studies. Use of a bivalent 
P. haemolytica/P. multocida bacterin was found to have no effect 
on reduction of clinical and pathological signs compared to controls 
(Amstutz et al., 1981). In a later study, use of a similar bacterin 
resulted in a significant reduction ln the incidence of bovine 
respiratory disease and improved response to treatment. The difference 
between these two trials was suggested to be due to extraneous factors 
such as prior exposure, stress during shipment, or bacterial virulence 
(Morter et al., 1982). In many field studies, the effect of bacterins 
was either minimally positive or had no effect (Martin, 1983). In 
contrast, several reports have indicated that bacterins may cause 
adverse effects and enhance the disease. Friend et al. (1977), 
vaccinated calves with P. haemolytica bacterin both subcutaneously 
and by aerosolization, then exposed the calves intratracheally with 
live P. haemolytica. The degree of pneumonia correlated positively 
with antibody reponse to P. haemolytica as measured by either the 
whole cell agglutination or indirect bacterial agglutination tests. 
This adverse response was suggested to be due to an immune-mediated 
hypersensitivity pneumonitis. Using the same bacterin and challenge 
method, Wilkie et al. (1980) obtained similar results. They found that 
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subcutaneous vaccination resulted in adverse clinical and pathological 
effects, whereas intrabronchial vaccination may have induced minor 
protection. The reason for the adverse effect of systemic vaccination 
may have been due to the stimulation of IgG opsonizing antibody which 
enhanced phagocytosis and cytotoxin-mediated destruction of leukocytes. 
These results demonstrated the questionable value of bacterins, and 
indicated that other factors must be considered to obtain consistent 
protection against the disease. 
The association of parainfluenza-) (PI-3) v~rus with Pasteurellae 
in many cases of shipping fever prompted the inclusion of PI-3 vaccines 
with bac terins. In early studies, inactivated PI-3 was used either 
alone, or in combination with P. haemolytica and P. multocida. 
Hemagglutination inhibition titers to PI-3 generally increased ~n 
vaccinated animals, but no obvious reductions in the incidence of 
clinical signs or respiratory disease were detected between vaccinated 
and non-vaccinated groups following shipment (King et al., 1963; Gale 
et al., 1963). Calves given an inactivated PI-3, P. haemolytica, 
and P. multocida vaccine followed by an experimental challenge 
consisting of stress and an aerosol of PI-3, P. haemolytica, and~ 
multocida were found to have an increased resistance to disease 
(Matsuoka et al., 1966; Hamdy and Trapp, 1964). These results suggested 
that this vaccine combination stimulated a good immune response against 
experimental challenge. Vaccination with various combinations of 
formalinized PI-3, P. haemolytica, and P. multocida, and modified 
live infectious bovine rhinotracheitis (IBR) virus produced substantial 
protection against experimental challenge exposure by either PI-3, ~ 
haemolytica, and P. multocida, PI-3 and IBR, or IBR alone (Hamdy 
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and Trapp, 1964; Matsuoka et al., 1972) .. In studies using the same 
combinations under field condit~ons, however, the vaccines had no 
appreciable effects in protecting against clinically evident shipping 
fever (Hamdy et al., 1965). In another experiment, inactivated PI-3, 
P. haemolytica, and P. multocida vaccines caused an increase in 
the number of cases of shipping fever following weaning. PI-3 titers 
were higher in vaccinates than in controls, but this was not associated 
with any difference in the incidence of disease (Woods et al., 1974). 
Under feedlot conditions, one group of calves was given an IBR/PI-3 
vaccine, whereas another received IBR/PI-3 plus a P. haemolytica 
bacterin. Respiratory disease morbidity and mortality rates were 
consistently higher ~n the group receiving the bacterin than in the 
group receiving the viral vacc~ne alone (Bennett, 1982). Results of 
these last two studies suggest that the occasional adverse effects 
observed with the use of bacterins may also occur in vaccines containing 
viral- bacterial combinations. 
Viral vaccines have been used alone ~n attempts to reduce the 
incidence of pneumonic pasteurellosis. The rationale for this approach 
is that by preventing the predisposing viral infection, subsequent 
secondary Pasteurella sp. infections will not occur. Vaccination 
with PI-3 caused significant rises in hemagglutination-inhibition 
titers, but had only minimal effects on reducing the incidence of 
respiratory disease. It was found that the time of administration 
relative to weaning and the number of vaccinations given were important 
factors ~n determining the potential success of the vacc~ne (Woods et 
al., 1962). In several experiments, IBR-vaccinated or IBR/PI-3 
vaccinated calves had higher survival rates and less severe lesions 
23 
than unvaccinated controls following experimental challenge by either 
an aerosol of IBR, a combination of aerosol with IBR followed by~ 
haemolytica, or stress and transportation (Jericho et al., 1976; 
S to c kd a 1 e e t a 1 . , 1 9 7 9 a b) . Some of the viral vaccine-bacterin 
combinations have resulted 1n enhanced resistance to experimental 
challenge with the homologous organism. Under field conditions, 
however, viral vaccine-bacterin combinations still do not provide 
consistent and reliable protection (Collier, 1968; Anonymous, 1968; 
Engelbrecht, 1968). 
Live P. haemolytica vaccines have been used to try to stimulate 
a protective immunity. In calves vaccinated with live P. haemolytica 
by either aerosol or parenteral routes, transthoracic challenge lesions 
were less severe than in control animals (Corstvet et al., 1978; 
Panciera et al., 1984). Calves vaccinated with live P. haemolytica 
by either route or calves which had been previously exposed naturally 
to the organism had high serum antibody titers to somatic antigens. 
These titers correlated with minimal experimental lesions (Panciera 
et al., 1984; Confer et al., 1984a,b). When logarithmic cultures of 
P. haemolytica were used as the immunogen, slightly greater resistance 
to challenge exposure occurred compared to when stationary phase 
organisms were used (Confer et al., -1984a). Vaccination with a 
chemically altered strain of P. haemolytica also provided various 
degrees of resistance to subsequent challenge by intranasal IBR and 
intratracheal P. haemolytica (Kucera et al., 1983). 
The more promising results obtained with live vaccines compared 
to bacterins could be due to several factors. In bacterins, bacterial 
surface membrane antigens are the primary stimuli for the immune 
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resulted 1n variable amounts of protection following an IBR, ~ 
haemolytica challenge (Yates et al., 1983). Parenteral routes appeared 
to provide much more protection than the aerosol route. These results 
sugg~sted that protection against pneumonic pasteurellosis may be 
possible with a subcellular extract of P. haemolytica. It is still 
unclear, however, which bacterial antigenic determinants are necessary 
for protection. 
In cattle which were vaccinated with a potassium thiocyanate 
extract of P. haemolytica, but subsequently developed pneumonia 
following experimental challenge, serum cytotoxin neutralizing activity 
was much lower than in similarly treated animals which did not develop 
pneumonia (Cho et al., 1984). High levels of cytotoxin neutralizing 
activity also have been detected in serum from cattle which have been 
either experimentally or naturally exposed toP. haemolytica, but 
did not develop evidence of disease. In contrast, low levels of serum 
anticytotoxin activity are commonly present in animals dying of 
fibrinous pneumonia (Cho et al., 1984; Shewen and Wilkie, 1983; Gentry 
et al., 1985). This evidence suggests a significant role for antibody 
against cytotoxin in protection from pneumonic pasteurellosis. The 
protective effects of immunization with antigens derived from cytotoxin, 
however, have yet to be determined. 
Exotoxins 
The production of extracellular enzymes that break down large 
molecules into smaller, usable units was an important step in the 
evolution of parasitism by certain microorganisms. A side effect of 
these enzymes and other products of bacterial metabolism is damage to 
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sys tern. With 1 ive organisms, however, capsular material, cytotoxin, 
and other bacterial products are produced and may also serve as antigens 
(Confer et al., 1984a,b; Panciera et al., 1984). The greater resistance 
to experimental challenge obtained when us~ng logarithmic phase versus 
stationary phase organisms as the immunogen suggests possible roles 
for these bacterial components ~n protection against pneumonic 
pasteurellosis (Confer et al., 1984a). 
Several studies on the protective effect of vaccines comprised 
of capsular extracts of Pasteurella have been undertaken in mice, 
hamsters, sheep, and cattle (Tadayon and Lauerman, 1981; Gilmour et 
al., 1979; Matsumoto et al., 1984; Yates et al., 1983). In mice and 
hamsters, a potassium thiocyanate extract of P. haemolytica yielded 
55% to 100% protection when compared to unvaccinated controls (Tadayon 
and Lauerman, 1981). In the same study, a saline capsular extract gave 
30% to 40% protection, whereas bacterins produced 20% to 60% 
protection. Testing of these extracts along with some other bacterial 
components suggested that bacterial immunogenic factors may be able 
to stimulate better immunity when freed from the bacteria than when 
the bacteria is still intact (Tadayon and Lauerman, 1981). In sheep, 
sodium salicylate extracted capsular material from P. haemolytica 
was antigenic and protective upon challenge exposure with aerosol PI-3 
and P. haemolytica (Gilmour et al., 1979). Results of vaccination 
of cattle with capsular material have been variable. With a saline 
extract of P. haemolytica no clear difference between vaccinated and 
non-vaccinated cattle could be detected following challenge exposure 
(Matsumoto et al., 1984). A potassium thiocyanate extract of !..:_ 
haemolytica given subcutaneously, intramuscularly, and by aerosol 
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the tissues and cells of the host. Since the first experiment 
demonstrating a detrimental effect of these enzymes (toxins) by Roux 
and Yersin in 1888, a wide variety of bacterial toxins have been 
isolated and described. In contrast to endotoxins, bacterial exotoxins 
are predominately protein, are produced by the bacteria during the 
logarithmic or declining phases of growth, are neutralized by homologous 
antibody, are heat-labile, and each have their own particular 
pharmacologic effects. Some of these have been purified and have well 
defined biological effects. Many others have less well understood 
mechanisms of action and it is unclear what role, if any, they play 
in the pathogenesis of disease (van Heyningen, 1970). Some of the more 
important exotoxins and general exotoxin classifications are summarized 
Ln Table I. 
A number of bacterial exotoxins have been reported to affect 
leukocytes. These affects include depression of chemotaxis and random 
mobility, inhibition of phagocytosis and intracellular killing, and 
complete cell lysis. The most extensively studied of these leukocyte 
toxins are the leukocidin of Pseudomonas aeruginosa and the 
Panton-Valentine leukocidin of Staphylococcus aureus. 
Pseudomonal leukocidin is produced by most strains of pathogenic 
P. aeruginosa. It is secreted as an inactive precursor which 
undergoes activation following protease (elastase) treatment (Scharmann, 
1976). The toxin is cytotoxic to neutrophils and lymphocytes of a wide 
variety of animal species, but has no effect on erythrocytes (Scharmann, 
1976b). A substance believed to be identical to leukocidin has been 
shown to inhibit phagocytosis and intracellular killing by neutrophils 
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involves an initial binding of the toxin to a single population of 
specific, but poorly characterized sites on the leukocyte membranes 
(Hirayama et al., 1984). These sites are most likely integral proteins 
of the plasma membrane and not lipid in nature (Scharmann, 1976c). 
The original hypothesis as to the mechanism of cytotoxicity was that 
membrane binding resulted in an increased permeability to low molecular 
weight substances based on the release of various intracellular markers 
from neutrophils exposed to leukocidin (Scharmann, 1976d). Subsequent 
studies found that the toxin stimulated a rapid turnover of 
phosphatidylinositol which resulted in increased levels of free 
cytoplasmic calcium. Increased calcium levels activated several 
membrane associated, calcium-dependent enzymes which may have been 
involved in the leukocidal process (Hirayama and Kato, 1983). The 
precise mechanism of toxicity remains unclear. 
Morphologic changes in neutrophils exposed to Pseudomonal 
leukocidin occur in three stages. Initially, there 1.s a rapid loss 
of cell motility and withdrawal of pseudopodia. Cytoplasmic protrusions 
containing granules appear on the surface of the cell. By 5 minutes 
post exposure, there is swelling and rounding of the cell; and by 30 
minutes, the nucleus is swollen and spherical and cytoplasmic 
architecture is poorly defined (Scharmann et al., 1976). 
Staphylococcal leucocidin is produced by several strains of 
Staphylococcus aureus. It consists of two components, F (Fast), and 
S (Slow), as determined by their migration on carboxymethylcellulose 
columns. The two components of leukocidin have been purified, 
crystallized, and partially characterized (Noda et al., 1980). 
Individually, these components are inactive, but when combined act 
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synergistically causing lysis of rabbit and human neutrophils and 
macrophages. A dermonecrotic effect on rabbit skin has also been 
attributed to the toxin, but otherwise the toxic complex appears to 
be highly specific for leukocytes (Ward and Turner, 1980). 
Extensive systematic studies into the mode of action of leukocidin 
were undertaken by Woodin and Wienke during the 1960°s (Woodin, 1970). 
The result of these studies led to a hypothesis that the major event 
in the mode of action of leukocidin is an altered membrane permeability 
to cations. Briefly, component F was postulated to interact with the 
hydrophobic portions of the cell membrane inducing expansion and a 
conformational change in F. Adsorption of the S component then occurs 
to the altered surface of the F component. Interaction of S with 
exposed hydrophilic portions of triphosphoinositide induces the creation 
of a membrane channel which is permeable to electrolytes. Potassium 
efflux and calcium influx increase the ionic strength of the region 
causing deformation of the F-membrarie complex and the subsequent release 
and dissociation of the S and F components into two inactive proteins. 
Membrane triphosphoinositide then reverts to its natural conformation 
and is capable of repeating the reaction with fresh leukocidin molecules 
(Woodin, 1970). More recent studies showed that pretreatment of rabbit 
neutrophils with the S component followed by exposure to the F component 
resulted in rapid lysis of the cells. In contrast, pretreatment with 
F followed by the addition of S was accompanied by a lag phase before 
cytotoxicity occurred. This suggested that the S component may be more 
responsible for the initial interaction with the cell membrane than 
the F component. Specific inactivation of the S component by 
ganglioside Gml and competitive inhibition of the binding of S to 
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leukocyte membranes by subunit B of cholera toxin, which utilizes a 
ganglioside Gm1 membrane receptor (van Heyningen,1971), indicates that 
ganglioside Gm1 may resemble or be part of the receptor site for 
component S (Noda et al., 1980). Binding studies have confirmed that 
S binds to a single type of membrane site without cooperative 
interaction. Component F, however, requires the presence of S before 
the full number of binding sites for it are expressed (Noda et al., 
1981). The examination of enzyme functions in leukocytes exposed to 
leukocidin showed high levels of membrane-associated component S induced 
phospholipase A2 activity. Upon exposure to component F, there was 
inhibition of binding of cyclic AMP to cyclic AMP-dependent protein 
kinase as well. Therefore the original hypothesis regarding the mode 
of action of leukocidin has been modified to reverse the roles of F 
and S. It was suggested that the binding of S component to ganglioside 
Gm1 receptors on the leukocyte membrane stimulates phospholipase A 
induced alterations in membrane phospholipids, thus allowing F to bind 
and induce an increased permeability to cations (Noda et al., 1982). 
Morphologic studies of rabbit leukocytes exposed to Staphylococcal 
leukocidin indicate that the sequence of events leading to leukolysis 
occur rapidly. Two minutes after exposure to the toxin, leukocytes 
are swollen, rounded, and have spherical instead of lobulated nuclei. 
Terminal events are characterized by cytoplasmic degranulation, nuclear 
rupture, appearance of empty intracellular vacuoles, and complete cell 
lysis. All of these effects were reported to be fully developed after 
only 10 minutes of incubation (Noda et al., 1980). 
Several of the bacterial-derived thiol-activated cytolysins affect 
leukocyte function and viability. The oxygen-labile hemolysin of 
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beta-hemolytic Streptococci, streptolysin 0, has been examined most 
thoroughly. At low concentrations, streptolysin 0 markedly depressed 
chemotaxis and random mobility of .human neutrophils. Neutrophils of 
several other species are affected also, but to a lesser extent (van 
Epps and Andersen, 1974; Andersen and van Epps, 1972). At higher 
concentrations, streptolysin 0 causes rapid degranulation and lysis 
of neutrophils and peritoneal macrophages (Hirsch et al., 1963; Ofek 
et al., 1972; Fauve et al., 1966). The mechanisms of these effects 
have been hypothesized to be due to either an alteration of leukocyte 
membrane permeability by toxin-cholesterol complexes, or a toxin induced 
configurational change in a membrane protein causing premature 
activation of the respiratory burst mechanism. In the latter, there 
would be subsequent formation of toxic oxygen intermediates ultimately 
resulting in cellular dysfunction and death (Andersen and Duncan, 
1980). 
A cell bound hemolysin of Group A Streptococci, streptolysin S, 
has been shown to produce similar effects on leukocytes. This toxin 
is distinct from streptolysin 0 and has different biochemical 
properties. The toxicity of streptolysin S is much less than 
streptolysin 0 and is dependent upon the toxin being either cell 
associated or bound to an extracellular carrier protein. The toxic 
mechanism is unclear, but may involve penetration of the cell membrane 
and damage to the subcellular organelles (Ofek et al., 1970; Hirsch 
et al., 1963; Ofek et al., 1972). 
Pne~molysin is the sulfhydryl-activated cytolysin of Streptococcus 
pneumoniae. Like streptolysin 0, low doses of pneumolysin inhibit 
chemotaxis and random migration while higher doses cause cell death 
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and lysis of human neutrophils (Johnson et al., 1981; Paton and 
Ferrante, 1983). Immunization of mice with purified pneumolysin 
followed by aerosol challenge with virulent S. pneumoniae resulted 
in significantly longer survival times in immunized mice compared to 
non-immunized controls. High circulating antibody titers to pneumolysin 
correlated positively with increased resistance against S. pneumoniae 
challenge. These findings suggest that pneumolysin may play a role 
in the pathogenesis of S. pneumoniae in mice, most likely by its 
effects on neutrophils (Paton et al., 1983). 
Leukocidal effects on macrophages have also been detected with 
the sulfhydryl-activated cytolysin of Listeria monocytogenes. These 
effects were not present when macrophages were exposed to non-hemolytic 
Listeria strains. This toxin remains poorly characterized, however, 
and its role in listerial infections is unclear (Kingdon and Sword, 
1970; Watson and Lavizzo, 1973). 
Several repor~s of leukocidal activity have also been made on some 
unrelated toxins. An alpha hemolysin of E. coli has been shown to 
depress phagocytosis and chemotaxis by human leukocytes (Cavalieri and 
Snyder, 1982). At higher concentrations, this toxin is cytolytic for 
these cells (Cavalieri and Snyder, 1982b). Staphylococcal alpha toxin 
depresses phagocytosis by and decreases viability of human neutrophils 
(Gemmell et al., 1982) and rabbit alveolar macrophages (McGee et al., 
1983). A delta hemolysin of Staphylococcus sp. caused complete lysis 
of neutrophils, monocytes, and lymphocytes from a variety of different 
species (Gladstone and Yoshida, 1967). Certain strains of 
Actinobacillus actinomycetemocomitans, a Gram negative organism which 
plays an important role in certain types of periodontal disease, 
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produces a leukotoxin which is cytocidal for human neutrophils and 
monocytes (Tsai et al., 1979; Taichman et al., 1980). The toxin appears 
to act at the cell membrane, but the mechanism of toxicity does not 
appear to be due to osmotic lysis caused by extensive permeability 
changes (Taichman et al., 1980). The isolation of a significantly 
higher number of leukotoxin producing ·strains of bacteria compared to 
non-leukotoxin producing strains of bacteria from patients with 
periodontal disease supports the hypothesis that leukotoxin may be an 
important virulence factor in the pathogenesis of certain forms of 
periodontal disease (Zambon et al., 1983; Tsai et al., 1979). 
There have been several reports of a substance produced by 
Fusobacterium necrophorum which is toxic for neutrophils, lymphocytes, 
and peritoneal macrophages (Fales et al., 1977; Roberts, 1967; 
Coyle-Dennis and Lauerman, 1978). Original reports were of a heat 
stable toxin, which may have been endotoxin. The most recent isolate, 
however, was heat labile and had characteristics typical of an exotoxin 
(Coyle-Dennis and Lauerman, 1978). Using a mouse model, it was found 
that leukotoxin producing strains of Fusobacterium necrophorum 
produced substantially more liver abscesses following intraperitoneal 
injection than non-leukotoxin producing strains. Those studies 
suggested a possible role for the leukotoxin in the pathogenesis of 
the lesions produced in this model system (Coyle-Dennis and Lauerman, 
1978). 
Haemophilus pleuropneumoniae, the cause of acute to chronic 
pleuropneumonia ~n swine, has been found to be toxic to porcine alveolar 
macrophages and blood monocytes. Both live bacteria and sterile culture 
supernatants were cytotoxic, whereas heat-killed organisms had no effect 
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on these cells. The toxin was heat-stable and could be neutralized 
by the sera of pigs with chronic Haemophilus pneumonia (Bendixen, 
1981). Previously, it had been shown that nonviable, sonicated~ 
pleuropneumoniae or sterile culture supernatants could induce localized 
pleuropneumonia when instilled into the lung (Rosendal et al., 1980). 
Together, these findings support a potential role for this toxin in 
the pathogenesis of porcine pleuropneumonia. 
Cytotoxin 
The first report of a P. haemolytica-associated cytotoxin was 
made by Benson et a1. (1978) Live cultures of P. haemolytica 
serotypes 1, 2, 7, and 12 were ·found to induce morphologic cytotoxic 
changes in and inhibit phagocytosis by alveolar macrophages in vitro. 
With heat-killed organisms, however, only mild cytotoxic changes and 
no inhibition of phagocytosis were noted. The toxic factor was also 
found in bacteria free filtrates of serotype 1. It was suggested that 
this toxic factor was either a product of metabolically active bacteria 
or a heat-labile substance of capsular origin. Markham and Wilkie 
(1980) measured the rate of phagocytosis by the uptake of 
formalin-killed, radiolabeled P. haemolytica. They found that 
macrophages phagocytized Yersinia enterocolitica more rapidly than 
macrophages which were incubated with P. haemolytica. The rate of 
phagocytosis of both organisms was enhanced by the presence of immune 
serum, but as the number of Pasteurella haemolytica organisms 
increased, this rate decreased. It was suggested that the increased 
uptake of opsonized bacteria occurring at high bacterial concentration 
was detrimental to alveolar macrophages. qigh bacterial numbers caused 
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an increased detachment of macrophages from coverslips which was 
suggestive of cell death. Chromium release assays, however, failed 
to demonstrate cytotoxixity in these macrophages exposed to whole 
formalin-killed bacteria. Low concentrations of bacteria free 
supernatents from P. haemolytica cultures were found to inhibit 
phagocytosis, while higher concentrations were found to cause 
cytotoxicity as determined by 51 Cr release. It was not determined 
whether the toxic material present in the culture supernatants was also 
present in association with the formalin-killed bacteria. Phagocytosis 
of live ~~]-thymidine labelled P. haemolytica by cultured alveolar 
macrophages also has been examined (Maheswaran et al., 1980). P. 
haemolytica were poorly phagocytosed in the absence of opsonins from 
normal adult bovine serum or P. haemolytica-specific antiserum. 
Incubation of cultured macrophages with low alveolar macrophage:bacteria 
ratios (1:10) resulted in complete phagocytosis and intracellular 
killing of bacteria with no evidence of cytotoxicity as determined by 
transmission electron microscopy. At a 1:20 ratio, however, some 
bacteria were not phagocytized and changes were noted in macrophages 
between 30 and 90 minutes of initial exposure. These changes were 
characterized by loss of cytoplasmic ground substance, decreased 
electron density of the cytoplasm, dispersion of nuclear chromatin, 
and eventually plasma membrane rupture. Changes were present in less 
than 10% of the alveolar macrophages at 30 minutes, but by 90 minutes 
almost all cells showed severe cytotoxic changes. It was suggested 
that the cytotoxic effect was due to a substance released by the excess 
unphagocytized bacteria (Maheswaran et al., 1980). Live P. 
haemolytica cultures were found to be cytotoxic to blood mononuclear 
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leukocytes by trypan blue exclusion (Kaehler et al., 1980a). In 
contrast, cytotoxicity was not detected when the cells were exposed 
to either heat-killed or x-irradiated P. haemolytica. Cytotoxicity 
was dose related as indicated by an increase in cell death as bacterial 
numbers were increased. Enriched monocyte cultures had a higher 
percentage cell death than lymphocyte cultures. It was speculated that 
phagocytosis of the bacteria by monocytes may speed their death, whereas 
lymphocytes were killed only after a certain concentration of bacteria 
was reached. The suggestion was made that the toxic factor was a 
property or product of metabolically active bacteria (Kaehler et al., 
1980a). P. haemolytica was also found to exert cytotoxic effects 
on sheep and goat blood mononuclear leukocytes (Kaehler et al., 1980b). 
Horse, swine, and human mononuclear leukocytes, however, were not 
susceptible. The specificity of the cytotoxin towards ruminant 
leukocytes was postulated to be due to a specific membrane receptor 
not present on non-ruminant leukocytes or due to differences in certain 
metabolic pathways in the cells of these species (Kaehler et al., 
1980b). Subsequent studies using sterile, bacterial culture 
supernatants, further delineated cell and species specificity of~ 
haemolytica cytotoxin (Shewen and Wilkie, 1982). Significant s~r 
release occurred with bovine alveolar macrophages, lymphocytes, 
neutrophils, and blood monocytes exposed to the toxic culture 
supernatant. Slight release was detected from cultured bovine kidney 
cells, porcine alveolar macrophages, lymphocytes, neutrophils, or 
monocytes. No release was present from bovine spleen cell cultures, 
or bovine or porcine erythrocytes. Because leukocytes are necessary 
to mount an immune response to bacterial infection, it was suggested 
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that neutral~zation of this cytotoxic component may be essential 1n 
prevention of pneumonic pasteurellosis (Shewen and Wilkie, 1982). 
A difference between the interaction of bovine neutrophils with 
logarithmic-phase versus stationary-phase P. haemolytica cultures 
has been determined. Berggren et al. (1981) found that 
logarithmic-phase organisms opsonized with normal bovine sera or 
anti-P. haemolytica sera were poorly phagocytized and caused release 
of 51 cr from the neutrophils. Under the same conditions, 
stationary-phase organisms were nearly all phagocytized and cytotoxicity 
was not detected. At higher bacteria to neutrophil ratios (100: 1), 
a smaller percentage of stationary-phase organisms were phagocytized 
and cytotoxicity occurred following prolonged incubation. This 
cytotoxicity was attributed to continued growth and elaboration of a 
toxic substance by unphagocytized bacteria. Transmission electron 
microscopy showed that at 10:1 bacteria : neutrophil ratios stationary 
phase organisms were completely phagocytized and degraded. In contrast, 
neutrophils exposed to the same number of logarithmic-phase bacteria 
showed marked cytotoxic changes characterized by cell membrane rupture, 
aggregated cytoplasmic matrices, and numerous cytoplasmic vesicles 
(Berggren et al., 1981). The same workers demonstrated that maximum 
51Cr release occurred when neutrophils were incubated with 6 hour 
bacteria cultures. Steadily declining amounts of §J.cr release were 
obtained from neutrophils incubated with 8-18 hour bacterial cultures. 
Adult bovine serum and antisera from calves inoculatated with 
logarithmic-phase organisms neutralized the cytotoxin. Bovine fetal 
serum and serum from neonatal calves, however, had no effect on 
cytotoxic activity. Cytotoxicity was confirmed by transmission electron 
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microscopy of neutrophils exposed to cytotoxin for 20 minutes. 
Morphologic changes included ruptu_red cell membranes, aggregation of 
cytoplasmic matrices, cytoplasmic vesicles, pyknotic nuclei, and 
evidence of lysosomolysis (Baluyut et al., 1981). Similar results were 
obtained using alveolar macrophages lavaged from calves at various 
intervals following aerosol exposure to P. haemolytica (Walker et 
al., 1984). Regardless of when the macrophages were obtained, 
logarithmic-phase P.haemolytica were poorly phagocytized and induced 
cytotoxicity. 
phagocytized. 
Stationary (declining)-phase organisms were 
Toxic changes were characterized by blunting of 
cytoplasmic processes, deb.ris filled cytoplasmic vesicles, and abundant 
extracellular debris. 
Purification and characterization studies of the cytotoxin have 
yielded variable results. In supernatant obtained from growth of P. 
haemolytica in RPMI-1640 medium without other growth additives, it 
was found that cytotoxic activity was retained by a 300,000 molecular 
weight cutoff membrane during ultrafiltration. This toxic supernatant 
was heat-labile, oxygen-stable, susceptible to pH extremes, inactivated 
by trypsin, and contained no detectable endotoxin. It was cytotoxic 
to both bovine neutrophils and monocytes and was not hemolytic to bovine 
or ov~ne erythrocytes (Baluyut et al., 1981). In another study, 
cytotoxin produced by P. haemolytica grown ~n brain heart infusion 
broth containing fetal calf serum ~n a dialysis culture system was 
isolated by ultrafiltration, and high pressure size exclusion gel 
chromatography. Supernatant subjected to gel filtration yielded three 
major peaks of interest. These were a void volume peak, a SOK protein, 
and a 150K protein. All 3 peaks reacted with polyvalent antisera to 
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P. haemolytica in double immunodiffusion tests. The highly purified 
150K antigen showed little to no cytotoxicity. Earlier less purified 
fractions which also contained this antigen along with growth factor 
components resulted in high cell mortality. Increased cell mortality 
could also be obtained by addition of the cationic detergent 
cetyltrimethylammonium bromide to the purified 150K antigen. Double 
immunodiffusion studies of the 150K and 50K antigens revealed convergent 
lines of identity suggesting that all antigenic determinants present 
in the 150K antigen were also present in the 50K antigen. 
Dithiothreitol reduction and sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) of the 150K antigen resulted in two major 
components of SOK and 20K. It was speculated that these were subunits 
of the 150K antigen and that the SOK component may be identical to the 
50K antigen obtained from gel filtration chromatography. Further double 
immunodiffusion studies with the 150K antigen showed lines of identity 
against 12 serotypes of P. haemolytica. This suggested that the 150K 
antigen could be used as a protective antigen against all major 
serotypes of P. haemolytica involved in bovine respiratory diseases 
(Himmel et al., 1982). 
Research Objectives 
Current evidence suggests an important role for P. haemolytica 
cytotoxin 1n the pathogenesis of pneumonic pasteurellosis. Major 
studies incriminating cytotoxin, however, have been made using crude 
bacterial supernatants. Two studies on the purification and 
characterization of cytotoxin have been reported and contain some 
conflicting and incomplete conclusions. The purpose of this study was 
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to purify cytotoxin for use in immunologic assays in order to more 
adequately determine the role of cytotoxin in pneumonic pasteurellosis. 
Chapter II 
PURIFICATION AND CHARACTERIZATION OF CYTOTOXIN 
Introduction 
Numerous predisposing factors have been implicated in the 
pathogenesis of shipping fever (pneumonic pasteurellosis) of cattle 
(Thomson, 1974; Thomson et al., 1975; Thomson, 1980; Lillie, 1974). 
The ultimate cause of clinical disease and death, however, is a 
severe fibrinous pneumonia caused by Pasteurella haemolytica serotype 1 
(Lillie, 1974; Jensen et al., 1976). Despite various approaches used 
to control the disease, pneumonic pasteurellosis continues to be a 
major economic problem to the feedlot industry (Jensen et al, 1976; 
Martin et al., 1980). 
P. haemolytica produces a toxin (cytotoxin) that is lethal for 
bovine leukocytes in vitro (Benson et al., 1978; Baluyut et al., 1981; 
Shewen and Wilkie, 1982). It has been suggested that cytotoxin 
participates in the pathogenesis of pneumonic pasteurellosis by either 
directly impairing lung defenses through its effect on alveolar 
macrophages and neutrophils, or indirectly by causing an inflammatory 
response mediated by lysosomal enzymes released from lysed leukocytes 
(Otulakowski et al., 1983). Serologic studies have demonstrated that 
high cytotoxin neutralizing antibody titers in both experimentally and 
naturally infected cattle are associated with increased resistance to 
pneumonic pasteurellosis (Shewen and Wilkie, 1983; Cho et al., 1984; 
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Gentry et al., 1985). These findings suggest an important role for 
cytotoxin in the pathogenesis of this disease. 
Initial characterization of cytotoxin demonstrated that it was a 
high molecular weight substance optimally produced by f.=._ haemolytica 
during their logarithmic growth phase (Baluyut et al., 1981). 
Cytotoxin was lethal to both bovine neutrophils and mononuclear 
leukocytes. It was also heat-labile, oxygen-stable, susceptible to pH 
extremes, and inactivated by trypsin (Baluyut et al., 1981). The toxic 
effect of this substance was neutralized by either adult bovine serum 
or serum from steers immunized with live f.=._ haemolytica. Subsequent 
chromatographic studies identified a 150 kilodalton (kDa) protein which 
was toxic to alveolar macrophages (Himmel et al., 1982). The protein 
migrated as a single band on polyacrylamide gel electrophoresis (PAGE) 
and was separated into 50 kDa and 20 kDa bands after complete 
denaturation and reduction on sodium dodecyl sulfate (SDS)-PAGE. 
Immunodiffusion tests demonstrated that the separated cytotoxic antigen 
cross reacted with antisera from 12 different f.=._ haemolytica serotypes. 
The purpose of the current study was to purify cytotoxin for more 
extensive examination of its biochemical, cytotoxic, and antigenic 
characteristics. 
Materials and Methods 
Crude Cytotoxin Preparation 
The most efficient production of crude cytotoxin was by the method 
of Shewen and Wilkie (1982). Lyophilized cultures of P. haemolytica 
biotype A, serotype 1 isolated from the trachea of a feedlot calf 
(Corstvet et al., 1973) were reconstituted in phosphate buffered saline 
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(PBS, O.OlM NaPo4 , 0.15M NaCl, pH 7 .4) and grown for 18 hours at 37° C 
on modified brain heart infusion agar • Isolated bacterial colonies 
were incubated in brain heart infusion broth for 4.5 hours, then 
transfered into RPMI-1640 medium (Gibco Laboratories, Grand Island, New 
York) containing 7% fetal bovine serum. Following a 1 hour 
incubation, bacteria were removed by centrifugation and the supernatant 
was filtered through a 0.2 urn membrane (Millipore Corporation, Bedford, 
Mass.). The filtered supernatant was then concentrated in a hollow 
fiber concentration system with a Model HlP-10-43 10,000 molecular 
weight exclusion hollow fiber cartridge (Amicon Corporation, Danvers, 
Ma.). Concentrated cytotoxin was dialysed against O.OlM Bis tris 
propane-Cl (BTP-Cl), pH 7.4, and stored at -60° C. 
Chromatography 
All chromatographic separations were conducted at 5° C. 
Concentrated crude cytotoxin equivalent to a volume of 20 liters of 
bacterial supernatant was applied to a 5 x 60 em column packed to a 
height of 43 em with DEAE Sephacel ( Pharmacia Fine Chemicals, 
Uppsala, Sweden), which was equilibrated with O.OlM BTP-Cl, pH 7.4. 
The sample was followed by 600 ml of O.OlM BTP-Cl buffer, and the 
column was then eluted with a 1500 ml linear gradient from 0 to O.lM 
NaCl in O.OlM BTP-Cl. Subsequent elution was by steps using NaCl 
concentrations of O.lM, 0.25M, and 0.5M in O.OlM BTP-Cl. The NaCl 
concentration of selected fractions was determined by conductivity. 
Fractions from ion exchange experiments which contained cytotoxic 
activity were pooled, concentrated and dialyzed against PBS. These 
samples were applied to a 2.6 x 100 em column packed to a height of 82 
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em with Ultrogel AcA-34 (LKB Biochrom Ltd., Gaithersburg, Maryland), 
and eluted with PBS. The column was calibrated for molecular weight 
determination (Andrews, 1965) with Blue dextran and proteins ranging 
in molecular weight from 13.7 kDa (ribonuclease) to 669 kDa 
(thyroglobulin) (Sigma Chemical Company, St. Louis, Mo.). Also 
included were catalase, albumin, chymotrypsin A, ferritin, aldolase, 
and ovalbumin. 
Fractions from gel filtration experiments which contained 
cytotoxic activity were pooled, concentrated, and dialyzed against 10 
mM Tris, pH 8.3. Samples were applied to a 1.6 x 30 em column packed 
to a height of 24 em with Polybuffer Exchanger 94 (Pharmacia Fine 
Chemicals, Uppsala, Sweden) which had been equilibrated with 10 mM 
Tris, pH 8.3. Elution was performed with 250 ml of polybuffer 74, 
adjusted to pH 4.0 with HCl followed by 10 mM Tris plus 0.5M NaCl, pH 
4.5. 
Cytotoxicity Assay 
Cytotoxicity of individual chromatographic fractions was 
determined by 51cr release from neutrophils. Bovine neutrophils were 
separated on Ficoll-Hypaque (Pharmacia Fine Chemicals, Uppsala, Sweden) 
with osmotic lysis of erythrocytes. Following three washes in PBS, 
neutrophils were suspended in RPMl-1640 medium to a concentration of 
lxl0 7 cells/ml. 51cr, as sodium chromate (ICN Radiochemicals, Irvine, 
Ca.) was added to the neutrophil suspension at a concentration of 50 
uCi/ml and the suspension was incubated for 1 hour at 37° in a shaking 
water bath. Neutrophils were washed three times in PBS and then 
resuspended in RPMl-1640 medium to a concentration of 8xl06 cells/ml. A 
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100 ul portion of the 51cr-labelled neutrophil suspension was added to 
each well of a 96-well round bottom cell culture plate (Corning Glass 
Works, Corning, N.Y.). Two hundred ul of the preparation to be assayed 
was added to triplicate wells and incubated for 1 hour at 37° C. The 
plates were centrifuged at 150 xg for 7 minutes and 200 ul of 
supernatant was transferred from each well to plastic tubes and counted 
for 4 minutes in an automatic gamma counter (Searle Analytical Inc., 
Des Plaines, Ill.). Mean counts and standard deviations were 
calculated for each fraction tested. 
For a more quantitative assay of cytotoxic activity, two-fold 
dilutions of pooled and concentrated fractions from various steps in 
the purification procedure were tested using 51cr release. Mean counts 
were plotted against dilution, and cytotoxin activity was defined as 
the inverse of the dilution required to produce 50% 51 cr release. 
Background counts and 100% release were determined with RPMI-1640 
medium containing 7% fetal bovine serum (FBS) and 4M NaOH 
respectively. The total cytotoxin activity was expressed either on a 
volume basis, or for specific activity adjusted according to the 
protein concentration. 
Immunologic Assays 
The reaction of individual chromatographic fractions with antisera 
to P. haemolytica was determined by an enzyme-linked immunosorbent 
assay (ELISA). The general procedure and preparation of bovine anti-P. 
haemolytica IgG and horseradish peroxidase (HRPO) conjugated anti-P. 
haemolytica IgG used in the assay have been previously described 
(Lessley et al., 1985). In the current study, plates were coated using 
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30 ug/ml of bovine anti-P. haemolytica IgG. HRPO-conjugated anti-P. 
haemolytica IgG was diluted 1:25 in PBS containing 0.05% Tween 20 and 
1% BSA. Absorbance was read at 490 nm (A490) on a manual ELISA reader 
(Bio-Tek, Burlington, Vermont). Results were reported as the average 
A490 for fractions minus the average A490 for PBS controls. 
Antibody response to purified cytotoxin was measured in rabbits 
and mice by ELISA (Voller et al., 1979). Doubling dilutions of serum 
from 1:100 to 1:1600 were tested in both species. For mice, plates 
were coated with 1 ug/ml cytotoxin in carbonate buffer. Alkaline 
phosphatase labelled anti-mouse IgG (Sigma Chemical Company, St. Louis) 
was used at a 1:200 dilution in PBS-Tween containing 1% BSA. For 
rabbits, plates were coated at 10 ug/ml cytotoxin in carbonate buffer 
and alkaline phosphatase labelled anti-rabbit IgG (Sigma Chemical 
Company, St. Louis, Mo.) was used at a dilution of 1:400 in PBS-Tween 
containing 1% BSA. The substrate consisted of 1 mg/ml p-nitrophenyl 
phosphate in 10% diethanolamine buffer. Absorbance was read at 405 nm 
(A405 ) on a manual ELISA reader. 
Rabbit and mouse serum were also reacted with cytotoxin in 
Ouchterlony immunodiffusion disks. The center wells of 0.9% agarose 
disks were charged with 10 ul of serum and the outer wells were filled 
with 10 ul of cytotoxin which was either undiluted or diluted 1:2, 1:5, 
or 1:10. The disks were incubated for 24 hours at 28° C in a 
humidified chamber. 
Anticytotoxin globulin and serum preparation 
Serum was obtained from a steer which was hyperimmunized with live 
P. haemolytica and possessed a high anti-P. haemolytica titer as 
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determined by a quantitative fluorometric assay (Confer et al., 1983). 
Serum was adsorbed with live encapsulated ~ haemolytica with stirring 
at 4°C for 3 hours to remove antibodies to somatic and capsular 
antigens. Following centrifugation and filtration, the adsorbed serum 
was fractionated by gel filtration on Ultrogel AcA-34. Fractions from 
each major protein peak were tested for their ability to neutralize 
crude cytotoxin in a 51 cr-release assay. Cytotoxic neutralizing 
capacity was demonstrated in the IgG fractions. These fractions were 
designated adsorbed sera and pooled, concentrated, and stored at -60 C. 
Antibody to cytotoxin was produced in 2 rabbits and 5 mice by 
injection of 100 ug purified cytotoxin in 1 ml Freund's incomplete 
adjuvant per animal. Three injections at 2 week intervals were given 
intradermally in rabbits and intraperitoneally in mice. 
Electrophoresis and Immunoblotting 
Pooled and concentrated samples from various stages of the 
purification procedure were subjected to SDS-PAGE, PAGE, and 
immunoblotting. Samples were adjusted to 0.5 mg protein per ml and 
denatured by heating in the presence of SDS and B-mercaptoethanol. 
Samples of 150 ul were applied to a 2% acrylamide stacking gel and a 
10% acrylamide resolving gel and separated by discontinuous SDS-PAGE 
(Laemmli, 1970). Some samples were also analyzed without denaturation 
in a 7.5% resolving gel by PAGE with discontinuous buffers (Davis, 
1964). Duplicate gels were run for each experiment. One gel was fixed 
and stained with Coomassie brilliant blue R 250. Proteins from the 
unstained duplicate gel were electrophoretically transferred onto a 
nitrocellulose membrane (Kirkegaard and Perry Laboratories, 
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Gaithersburg, Md.) in a Model TE 50 Transphor (Hoefer Scientific 
Instruments, San Francisco, Ca.) as previously described (Towbin et 
al., 1979; Lessley et al., 1985). Antigens were demonstrated using 
both adsorbed and non-adsorbed sera and autoradiography with 125r-
labelled protein A ( Amersham, Arlington Heights, Ill.). 
Isoelectrofocusing 
The isoelectric point of cytotoxin was determined by 
isoelectrofocusing in polyacrylamide gels containing ampholytes (LKB 
Ampholine PAGplates, pH 3.5-9.5; LKB-Produkter AB, Bromma, Sweden). 
Samples were electrophoresed on a flat bed electrophoresis apparatus 
for 1.5 hours at 30 watts and then stained with Coomassie Brilliant 
Blue R250. Isoelectric point determinations were made by comparisons 
with known standards (Pharmacia Fine Chemicals, Uppsala, Sweden) which 
were run with each gel. Included in the standards were 
amyloglucosidase, soybean trypsin inhibitor, B-lactoglobulin A, bovine 
and human carbonic anhydrase B, horse myoglobin, lentil lectin, and 
trypsinogen. 
Protein Assay 
Protein concentrations of pooled and concentrated cytotoxic 
fractions were determined by the method of Bradford (1976) using the 




Fractionation of Crude Cytotoxin 
The procedure used for separation of cytotoxin is outlined in 
Figure 1. Complete results of the separation procedure are listed in 
the appendix. The initial step in fractionation was anion exchange on 
DEAE-Sephacel (Figure 2). Typically, anion exchange separations 
produced two large absorbance peaks, the first peak eluting sharply 
with 0.05 M NaCl followed by a broader peak e~uting from O.lM to 0.2M 
NaCl. Four regions of cytotoxicity were detected (Figure 3). Two 
major regions of cytotoxicity were associated with fractions 95-120 
(Region 1) and fractions 135-180 (Region 2). The regions of minor 
cytotoxic activity at fractions 185-205 and 215-235 were not toxic 
upon subsequent gel filtration analysis and were not pursued further. 
By ELISA a broad, region of increased absorbance was shared by both 
Region 1 and Region 2 .· 
Gel filtration of the concentrated fractions from Region 1 
resulted in a large absorbance peak eluting between fractions 40 - 60. 
A single, broad peak of cytotoxicity occurred in association with this 
large absorbance peak. Maximum cytotoxic activity eluted at a position 
corresponding to a molecular weight of approximately 160 kDa. There 
was increased absorbance associated with these fractions on ELISA. 
Cytotoxic fractions obtained from gel filtration of Region 1 material 
were pooled and concentrated. In subsequent chromatographic 
separations of this pooled material, however, cytotoxicity could not 
be detected. 
Gel filtration of the concentrated fractions from Region 2 yielded 
Figure 1 Cytotoxin Purification Schemeo 








































Crude Cytotoxin - Anion Exchange Chromatography. 
Absorbance (-) and conductivity ( -----) of 
chromatographic fractions. Region 1 and Region 
2 indicate fractions demonstrating cytotoxicity. 
Crude Cytotoxin - Cytotoxicity. 
5lcr release assay of fractions obtained from anion 
exchange chromatography. 
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two major absorbance peaks at fractions 40 - 55 and 70 - 95 (Figure 4). 
A large plateaued peak of cytotoxic activity eluted between these two 
major areas of absorbance corresponding to a molecular weight of 160 
kDa (Figure 5). Upon gel filtration of material from both Region 1 and 
Region 2, variable amounts of cytotoxicity were detected in the 
vicinity of fractions corresponding to a molecular weight of 30 kDa. 
Pooled and concentrated cytotoxic f~actions obtained from gel 
filtration separations of Region 2 material failed to bind to 
chroma to focusing columns equilibrated at pH 8.3 and pH 7 .4. A 
substantial amount of non-cytotoxic material did bind at pH 8.3, 
however, resulting in additional purification of the cytotoxic 
component (Figures 6 and 7). 
Additional manipulation of cytotoxin demonstrated retention of 
s u f f i c i en t c y t o t o x i c i ty a t pH 4 • 5 f o r d e t e c t i on in d i 1 u t e 
chromatographic fractions. At pH values over 9.5 detection of 
cytotoxicity was inconsistent. Dialysis of cytotoxin into 0.3M KH 2Po4 
resulted in decreased cytotoxic activity. Dialysis of this material 
back into O.OlM KH2Po4 , however, resulted in the return of substantial 
amounts of cytotoxicity. 
A quantitative summary of the purification procedure is 
presented in Table II. Increases in cytotoxic activity expressed as a 
function of protein concentration were not observed even as associated 
non-cytotoxic protein components of the sample were removed. The 
entire separation procedure resulted in a 97% reduction in protein 
content of the original sample with a 1.3% recovery of the total 
original cytotoxic activity. 
Figure 4 
Figure 5 
Region 2 Material - Gel Filtration Chromatography. 
Absorbance of fractions obtained from gel filtration 
of anion exchange fractions 135-180 (Region 2). 
Re3ion 2 Material - Cytotoxicity. 
1cr release assay of fractions obtained from gel 
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Gel Filtration Cytotoxin - Chromatofocusing. 
Absorbance of fractions obtained by chromatofocusing 
of Region 2 gel filtration fractions 35-70. 
Gel Filtration Cytotoxin - Cytotoxicity. 
5lcr release assay of fractions obtained by chromatofocus-


















































Crude CF 346 
Ion Exchange 
Region 1 47 
Region 2 50 
Gel Filtration 
Region 1 127 
Region 2 276 
Chromatofocusing 
Region 2 94 
TABLE II 
CYTOTOXIN PURIFICATION PROCEDURE: SUMMARY 
Protein Total Cytotoxin Cytotoxin Total 
mg/ml Protein units units Cytotoxin 
mg /ml /mg units 
120 41,520 2. 515 20.96 1170,190 
160 7,520 455 2.84 21,360 
266 13,300 10,265 311.59 513,250 
55 6,985 310 5.64 39,370 
11.9 3,284 395 33.19 109,020 






















Low Molecular Weight Cytotoxin 
To further investigate the occasional occurrence of low molecular 
weight cytotoxic fractions in gel filtration experiments, a pooled and 
concentrated sample of anion exchange fractions from Region 2 was split 
into two portions. One sample was analyzed by gel filtration 
immediately and yielded absorbance and cytotoxicity profiles similar to 
those described previously (Figure 8). The second sample was allowed 
to age for 3 weeks at 4 C prior to application to the column. The aged 
sample yielded an absorb.ance and cytoxicity profile similar to the 
fresh sample, except that an additional moderately sized cytotoxic peak 
eluted at a position corresponding to a molecular weight of 
approximately 30 kDa (Figure 9). By ELISA, increased absorbance was not 
associated with this small molecular weight peak. 
Cytotoxic Activity 
Two types of titration curves were obtained during the 
determination of the cytotoxic activity present in each of the major 
separated, pooled cytotoxic regions (Figure 10). Material from early 
in the separation process usually showed an abrupt decline in 
cytotoxicity at low (1:2 and 1:4) dilutions, a plateau region, and a 
linear decline in cytotoxicity at high dilutions ()1:64). Titration 
curves of more purified material obtained later in the process 
generally exhibited linear declines in cytotoxicity which reached 
baseline values at high dilutions. The intensity of Region 2 
cytotoxicity seemed to decline with time, but was easily detected 
throughout the separation process. 
Figure 8 
Figure 9 
Region 2 Material (Fresh) - Gel Filtration Chromatography and 
Cytotoxicity. Absorbance (---) and Slcr release assay 
(-r-) profiles of fractions obtained from gel filtration of 
Region 2 Material. Region 2 Material was subjected to gel 
filtration immediately after it was obtained from anion ex-
change experimentso 
Region 2 Material (Aged) - Gel Filtration Chromatography and 
Cytotoxicity. Absorbance (---) and 51cr release assay 
{~) profiles of fractions obtained from gel filtration of 
Region 2 Material. Region 2 Material was subjected to gel 
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Figure 10 Titration of Major Cytotoxic Regions. 
51cr release assays of serial dilutions of cytotoxin pre-
parations obtained at major steps in the purification pro-
cedureo Gel filtration (High M.W.) represents fractions 
35-70 obtained from gel filtration of Region 2 Material. 
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The ELISA used for detection of antigen associated with live K!_ 
haemolytica consistently demonstrated increased absorbance associated 
with the 160 kDa cytotoxic fractions obtained from gel filtration 
experiments. 
The ELISA used for detection of antibodies to purified cytotoxin 
in rabbit and mouse sera showed higher A405 values for sera obtained 
after inoculation compared to pre-inoculation sera. The mean pre-
inoculation A405 in rabbits was 0.172t0.010. Sera obtained following 
three inoculations had a mean A405 value of 1.668±0.071. In mice, the 
mean pre-inoculation A405 was 0.162±0.015. Sera obtained following 
three inoculations had a mean A405 value of 0.870±0.098. 
Immunodiffusion tests using rabbit serum demonstrated single lines 
of precipitation between the serum and all cytotoxin dilutions. In 
mice, two lines of precipitation were obtained between the serum and 
each cytotoxin dilution. 
Electrophoresis and Immunoblotting 
Non-denaturing PAGE of the purified material from Region 2 
resulted in 3 protein bands (Figure 11). A major band occurred with a 
relative mobility (Rf) of 0.63. Two other bands migrated closely 
together with relative mobilities of 0.37 and 0.42. When BSA was 
electrophoresed in the same system, a mobility of 0.63 was obtained for 
the monomer. Immunoblotting with adsorbed sera resulted in a strong 
binding of antibody in association with the Rf 0.37 and 0.42 bands. No 
reaction occurred with the Rf=0.63 band. 
Figure 11 Purified Cytotoxin - PAGE and Immunoblotting. 








SDS-PAGE of the same material after complete denaturation and 
reduction resulted in the identification of four primary protein bands 
after staining with Coomasie (Figure 12). The first was a broad, faint 
band with an apparent molecular weight corresponding to 160 kDa. Two 
intensely stained bands were present having molecular weights of 66 kDa 
and 57 kDa, respectively. A faint, but very sharp band was also 
present at approximately 23 kDa. Several faint, indistinct bands were 
scattered among these major bands. Immunoblotting using unadsorbed 
serum resulted in a smeared zone of antibody binding from 160 to 80 
kDa, with dark, distinct bands visible at 66 kDa and 57 kDa. A very 
faint reaction occurred at 23 kDa. In contrast, immunoblotting using 
the more specific adsorbed sera yielded two strong bands at 66 and 57 
kDa (Figure 12). Only faint, indistinct background reactions were 
observed from 50 to 100 kDa. No reaction occurred with the 160 kDa 
band with either adsorbed or non-adsorbed sera. 
SDS-PAGE of pooled fractions from the high molecular weight and 
low molecular weight regions of cytotoxicity obtained from gel 
filtration of fresh and aged Region 2 material is shown in Figure 13. 
Pooled samples of the material eluting between fractions 45 - 60 
contained the four major protein bands previously described. There was 
a shift of staining intensity, however, from the 160 kDa band to the 
57 kDa band in the aged sample relative to the fresh one. In the 
material eluting between fractions 70 - 85, bands common to both 
samples were present at 75, 66, 57, and 14 kDa. Bands at 45 kDa and 54 
kDa were present in the aged sample, but not clearly distinguishable 
in the fresh one. The fresh sample, however, contained a substantially 
larger, more intense band at 57 kDa than that for the aged sample. 
Figure 12 Purified Cytotoxin - SDS-PAGE and Immunoblotting. 








Figure 13 Region 2 Material (Fresh and Aged) - SDS-PAGE and 
Immunoblotting. Fresh (A) and Aged (B) high molecular 
weight proteins (gel filtration fractions 35-70)o Fresh 
(a) and aged (b) low molecular weight proteins (gel 
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Immunoblotting of the high molecular weight material from both the 
fresh and aged samples with unadsorbed serum gave distinct bands at 66, 
57, and 23 kDa. Lightly stained background reactions were present from 
160 to 80 kDa. No antigenic bands were present with the low molecular 
weight material from either sample. 
Isoelectrofocusing 
Isoelectrofocusing resulted in the separation of purified 
cytotoxin into several prominent protein bands and some faint, less 
prominent protein bands. These bands migrated closely together and had 
isoelectric points ranging from 4.6-5.2. 
Discussion 
The results of these experiments have demonstrated a 
straightforward procedure for obtaining relatively purified P. 
haemolytica cytotoxin. The procedure requires three chromatographic 
steps and successfully removes a large portion of the BSA and other 
non-bacterial serum proteins which are necessary for efficient 
cytotoxin production. The final product, though not biochemically pure 
as determined by electrophoresis, retains its cytotoxic and immunologic 
properties, thus allowing further investigation of these 
characteristics. 
On the basis of these studies native ~ haemolytica cytotoxin 
appears to be a 160 kDa protein. In non-denaturing PAGE, cytotoxin 
separated into 2 protein bands which were associated with a broad 
region that bound antibodies present in adsorbed serum. A third band 
appeared to be BSA. Following denaturation, four distinct protein 
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hands were present in SDS-PAGE (160, 66, 57, and 23 kDa). Two of these 
(66 and 57 kDa), reacted with antibodies in adsorbed sera. These 
results suggest that cytotoxin is composed of subunits or is a single 
polypeptide which can undergo intrachain cleavage. 
The results of 51cr assays of Region 2 gel filtration fractions 
demonstrated the consistent presence of cytotoxic activity associated 
with the native 160 kDa protein. In addition an approximately 30 kDa 
cytotoxic, hut immunologically non-reactive substance, was found in 
occasional preparations. The incidence of this low molecular weight 
cytotoxic material increased in aged samples and appeared to occur as a 
result of degradation of the 160 kDa cytotoxin. The breakdown of the 
160 kDa cytotoxin into smaller cytotoxic components under the mild 
conditions of this experiment suggest either an inherent instability of 
the molecule or the possible presence of proteolytic substances in 
Region 2 material. A neutral protease produced by ~ haemolytica has 
been reported and could be at least partially responsible for this 
degradative process (Otulakowski et al., 1983). From the available 
evidence, it is not clear whether the low molecular weight cytotoxic 
material and the immunologically non-reactive 23 kDa band detected on 
SDS-PAGE are related. 
Himmel et al. (1982) reported the isolation of an immunogenic and 
toxic 150 kDa protein from ~ haemolytica in a dialysis culture system 
with brain-heart infusion and calf serum growth medium. This protein 
migrated as a single band on PAGE and was reduced to a 50 kDa and a 20 
kDa hand with SDS-PAGE. In some experiments where aged cells were 
used to inoculate the growth medium the 150 kDa protein was replaced by 
a highly immunogenic 50 kDa protein. Double immunodiffusion studies of 
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the 150 kDa and 50 kDa antigens demonstrated common antigenic 
determinants. These authors suggested that the 50 kDa antigen was a 
subunit of the 150 kDa protein. 
The results of the current investigation are similar to those 
described above, except that an additional 66 kDa protein was detected. 
On the basis of molecular weight, this protein may have represented 
BSA. However, immunoblots of native cytotoxin separated by SDS-PAGE 
which were developed with adsorbed sera produced a strong reaction with 
this 66 kDa protein. In contrast, immunoblots of BSA separated by PAGE 
and developed with the same sera failed to result in any antibody 
binding. These findings suggest that the 66 kDa protein represents 
either a distinct component of cytotoxin, or may represent a complex of 
BSA with a small molecular weight fragment of cytotoxin. The 66 kDa 
antigen could also represent an intermediate form of one or more of the 
final cytotoxin breakdown components. 
The 66, 57, and 23 kDa proteins obtained in this study appear to 
be distinct from the 42 and 30 kDa outer membrane proteins which have 
b e e n e x t r a c t e d f r o m P • h a e .!!!£.!.z.!..!..!:.!!. ( S q u i r e e t a 1. , 1 9 8 4 ) . 
Immunoblotting with hyperimmune anti-~ haemolytica serum of SDS-PAGE 
preparations of proteins separated from a saline extract of P. 
haemolytica resulted in the demonstration of 10 distinct antigens 
(Lessley et al., 1985). Included among these antigens were common 
bands at 62 and 24 kDa as well as a unique 56 kDa band which was 
present in one of the proteins. Whether any of these are related to 
the protein components isolated from cytotoxin is unknown. The saline 
extracts from which these antigens were obtained were not toxic to 
bovine neutrophils (Gentry, 1984). 
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Certain properties of various cytotoxin preparations have been 
described (Baluyut et al., 1981; Himmel et al., 1982), but the precise 
range of biochemical parameters necessary for cytotoxicity, 
immunogenicity, and many general characteristics of cytotoxin are still 
unclear. During the course of chromatographic experiments in this 
study several features of cytotoxin were observed. Cytotoxin retained 
detectable activity within an approximate pH range of 4 to 9. Previous 
reports demonstrated considerable losses of activity at pH 3 to 6, with 
moderate losses at pH 9 and 10 (Baluyut et al., 1981). 
In the current study, high phosphate concentrations seemed to have 
a detrimental, but reversible effect on the cytotoxic activity of 
partially purified cytotoxin. Subsequent preliminary experiments 
evaluating the effect of various divalent cations on cytotoxicity 
failed to show any obvious effects (unpublished data). The presence of 
certain metal chelators, however, did seem to enhance cytotoxicity in 
some cases. The significance of these findings is unclear, but might 
indicate a certain sensitivity of cytotoxin to increases in ionic 
strength or reduction of divalent cation concentrations. 
While native cytotoxin tends to form fairly distinct protein bands 
on PAGE, immunoblots using adsorbed sera demonstrated antibody binding 
over a broad area associated with these bands. This suggests that 
native cytotoxin may be heterogeneous in charge or molecular weight, 
possibly due to a high carbohydrate content. A heterogeneous charge 
is also suggested by the relatively wide range of ionic strengths over 
which cytotoxin eluted on anion exchange chromatography. The 
isoelectric point of purified cytotoxin was found to range between 4.6-
77 
5.2. This is in contrast to the previously estimated value of 9.7 
(Himmel et al., 1982). 
Purified cytotoxin was found to be immunogenic in both rabbits and 
mice. Rabbits recognized a single antigen, whereas mice reacted to two 
distinct ant"igens. 
A major problem encountered throughout these experiments was the 
progressive loss of cytotoxic activity as the purification process 
progressed. Some of this loss may have occurred due to physical 
absorption of cytotoxin to membranes used during concentration. It 
seems likely, however, that at least part of this loss resulted from 
degradation or alteration of cytotoxin. Similar declines in 
cytotoxicity with increased purification have been previously seen and 
attributed to the variability in cells used for the cytotoxicity assay 
and the presence of additional growth factors in less purified 
cytotoxic samples (Himmel et al., 1982). The cause of the rapid loss 
of cytotoxic activity in Region 1 material is unknown. Gel filtration 
showed it to be 160 kDa in size, but further analysis is necessary to 
determine if it is the same as the Region 2 cytotoxin or represents a 
different substance. 
The shape of titration curves of pooled cytotoxic fractions 
obtained at each step of the separation procedure seemed to be 
dependent upon the protein concentration of the sample. Early samples 
containing large amounts of protein demonstrated prominent plateau 
regions whereby continued dilution had no effect on cytotoxicity. At 
higher dilutions, linear declines in cytotoxicity occurred. More 
purified samples, having lower protein concentrations, had rapid linear 
decreases in cytotoxicity with each increasing dilution. These results 
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suggest a possible buffering or stabilizing role for protein (mainly 
BSA) on the in vitro biological activity of cytotoxin. Possible 
mechanisms for this effect might be through protection of cytotoxin 
against proteolytic activity or stabilization of the basic structure of 
cytotoxin. Another possibility is that certain substances essential for 
the expression of cytotoxicity are removed during purification 
resulting in more rapid loss of activity with dilution. 
In conclusion, the result of this study was the acquisition of mg 
quantities of a partially purified ~ haemolytica cytotoxin which 
retained its immunogenic and toxic properties. Biological 
characteristics of the cytotoxin were demonstrated by analysis and 
titration of various chromatographed fractions derived from crude 
cytotoxin. The immunogenicity of cytotoxin and its components was 
demonstrated by immunoblotting, animal inoculation studies, ELISA, and 
immunodiffusion. Additional procedures are necessary, however, to 
obtain biochemically purified cytotoxin which still retains its 
biological and immunological properties. The precise role cytotoxin 
plays in pneumonic pasteurellosis will remain unclear until adequate 
amounts of relatively pure cytotoxin become available for continued in 
vitro use as well as for in vivo experimentation and vaccination 
studies. 
Chapter III 
SERUM ANTIBODY RESPONSE TO CYTOTOXIN 
Introduction 
Bovine pneumonic pasteurellosis (shipping fever) is a severe 
fibrinous pneumonia of feedlot cattle associated with infection by 
Pasteurella haemolytica biotype A serotype 1 (Collier, 1968; Lillie, 
1974; Jensen et al., 1976). Various approaches used to try to prevent 
the disease have proven largely unsuccessful such that pneumonic 
pasteurellosis continues to be a major problem to the feedlot industry 
(Jensen et al., 1976; Martin et al., 1980). 
Recent studies have concentrated on defining the role played by 
humoral immunity in resistance to shipping fever. Clinical use of P. 
haemolytica bacterins has not proven effective (Amstutz et al., 1981; 
Martin, 1983; Morter et al., 1982). Cattle given bacterins developed an 
antibody response to somatic antigens, but this response did not 
consistently result in protection against challenge by ~ haemolytica 
(Confer et al., 1985a; Gentry et al., 1985). Live !=_ haemolytica 
vaccines given by aerosol or parenteral routes resulted in enhanced 
resistance to experimental challenge (Panciera et al., 1984). 
Similarly, enhanced resistance to challenge was noted in calves having 
had prior natural exposure to the organism (Confer et al., 1984b). 
Further studies using live ~ haemolytica vaccines suggested a possible 
protective role for capsular antigens (Confer et al., 1984a). Several 
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studies have indicated that neutralizing antibody to P. haemolytica 
cytotoxin may play a role in increased protection against pneumonic 
pasteurellosis (Cho et al., 1984; Shewen and Wilkie, 1983; Gentry et 
al., 1985). 
Cytotoxin is an approximately 160 kDa protein which has been 
incriminated in the pathogenesis of pneumonic pasteurellosis through 
its toxicity to ruminant alveolar macrophages and peripheral blood 
leukocytes (Baluyut et al., 1981; Shewen and Wilkie, 1982). Antibody 
to cytotoxin has previously been measured only by labor intensive 
cytotoxin neutralization assays. The purpose of this study was to 
develop an enzyme-linked immunosorbent assay (ELISA) to detect serum 
antibody to purified cytotoxin, to compare antibody responses detected 
by ELISA to those detected by neutralization assays, and to determine 
the ELISA's potential as a predictor of resistance to experimental 
pneumonic pasteurellosis. 
Materials and Methods 
Serum Samples 
Sera were obtained from 5-8 month old calves which had been used 
in previous experiments evaluating the effect of various forms of 
vaccination on resistance to pneumonic pasteurellosis. (Confer et al., 
1985a; Confer et al., 1984b; Panciera et al., 1984). Each calf was 
vaccinated subcutaneously with two doses of either PBS, ~ haemolytica 
bacterin (aluminum hydroxide adjuvant), or 5 x 109 colony forming 
units (CFU) of live ~ haemolytica (Corstvet et al., 1978; Panciera et 
al., 1984; Confer et al.; 1985a). Vaccinations were given on days 0 
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and 7. Serum samples were collected on days 0,7,14, and 21 and stored 
at -70° C. On day 21, calves were experimentally exposed by 
transthoracic injection with 5 ml of ~ haemolytica containing 
approximately 1 x 109 CFU/ml (Panciera and Corstvet, 1984). On day 25, 
calves were sacrificed and lung lesions were evaluated to determine the 
extent of lung resistance to challenge exposure (Panciera et al, 1984). 
Numerical scores were awarded on the basis of morphologic criteria 
which included the size of the lesion and the degree of extension of 
inflammation from the original lesion site. A maximum score of 20 
represented a severe lesion and lack of resistance whereas lower scores 
corresponded to increased resistance. A total of 12 calves from each 
vaccination group were used in the study. 
Serologic Evaluation 
Antibodies to somatic antigens of ~ haemolytica were determined 
by a quantitative fluorometric immunoassay (FlAX, International 
Diagnostic Technology, Santa Clara, Calif.) using formalin-killed 22 
hour cultures of P. haemolytica serotype 1 as the antigen. (Confer et 
al., 1983). 
Serum cytotoxin neutralization titers were determined as 
previously described (Cho et al., 1984; Shewen -and Wilkie, 1983; Gentry 
et al., 1985). In general, these determinations were made by 
preincubation of serial two-fold dilutions of test sera with crude 
cytotoxin followed by cytotoxicity assays using 51 Cr release from 
bovine leukocytes to measure cell viability. 
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Anticytotoxin ELISA 
The antigen used in the ELISA was a partially purified cytotoxic 
protein obtained from supernatants of logarithmic- phase cultures of ~ 
haemolytica. The protein was separated from crude ~ haemolytica 
supernatants by anion exchange chromatography, gel filtration, and 
chromatofocusing as previously described (Chapter II), and was 
designated as purified cytotoxin. SDS-PAGE and immunoblotting of 
purified cytotoxin demonstrated two antigenic bands when reacted with 
antisera to live P. haemolytica which had been adsorbed with formalin-
killed bacteria to remove antibody to capsular and somatic antigens. 
Optimal conditions for the ELISA were determined from preliminary 
experiments using antigen coating concentrations of 0.01 ug, 0.1 ug, 
and 1 ug per 100 ul, serum dilutions from 1:50 to 1:1600, and conjugate 
dilutions of 1:200 and 1:400. 
For routine assays, 100 ul of antigen diluted to 10 ug/ml in 
carbonate buffer, pH 9.6, was placed in each well of 96-well 
polystyrene plates (Nunc, Denmark) and incubated overnight at room 
temperature on a rocker platform. Plates were washed 3 times with PBS 
containing 0.05% Tween 20 (PBS-Tween). For each serum sample tested, 
100 ul of a 1:400 dilution in PBS-Tween containing 1% bovine serum 
albumin (BSA) was added to duplicate, wells and incubated for 1 hour. 
Following 3 washes with PBS-Tween, 100 ul of a 1:200 dilution of 
horseradish peroxidase conjugated, affinity purified anti-bovine IgG 
in PBS-Tween-1% BSA was placed in each well. After a 1 hour 
incubation, the plates were washed 6 times with PBS-Tween. For color 
development, 100 ul of substrate, consisting of of a-phenylenediamine 
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and hydrogen peroxide in phosphate-citric acid buffer was added to each 
well and the plates were incubated for 45 minutes in the dark. The 
reaction was stopped by addition of 50 ul of 2.5M H2so4 , to each well 
and the absorbance at 490 nm (A490) was determined on a manual ELISA 
reader (Bio-Tek, Burlington, Vermont). The reported A490 for each 
sample was the average of duplicate wells. To compare samples from 
different plates, A490 readings were standardized on the basis of a 
positive control (sera from a steer hyperimmunized with live P. 
haemolytica) and a negative control (PBS) which wer~ determined on 
each plate. 
Adsorption Experiments 
Selected sera were used to study the specificity of the ELISA by 
preadsorption of the sera with several f.:_ haemolytica antigens. For 
each sample, 100 ul of serum was diluted 1:200 in PBS-Tween-1% BSA and 
then incubated with no equal volume of either purified cytotoxin, a 
saline extract of f.:_ haemolytica (Gentry et al., 1982), formalin-killed 
f.:_ haemolytica, or PBS. Cytotoxin and capsular extract were used in 
concentrations of 1000 ug, 100 ug, 10 ug, and 1 ug per ml, whereas 
formalin-killed bacteria were used at 1010 , 109 , 108 , and 10 7 CFU 
equivalents as determined spectrophotometrically (Confer et al., 1983). 
Mixtures were incubated overnight at 4° C on a rocker platform in 96 
well round bottom tissue culture plates (Corning). Adsorbed sera were 
then assayed using the ELISA procedure as previously described. 
Statistical Evaluation 
The antibody responses to cytotoxin determined using ELISA were 
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compared to FIAX titers, cytotoxin neutralizatfon titers, and lesion 
scores by multiple linear regression analysis (Statistical Analysis 
System, Cary, N. C.). Group means for the different vaccinates were 
evaluated by analysis of variance and least significant differences. 
Results 
Serial two-fold dilutions of sera from 1:50 to 1:1600 gave 
absorbance readings typical of an antibody response curve (Figure 14). 
Preadsorbtion of sera with PBS or various concentrations of a saline 
extract of P. haemolytica and formalin-killed P. haemolytica had no 
effect on cytotoxin antibody response (Figure 15). Preadsorption of 
the same sera with cytotoxin, however, resulted in dramatic decreases 
in cytotoxin antibody response at the two higher concentrations of 
cytotoxin. 
In calves vaccinated with live ~ haemolytica, there was a marked 
increase in ELISA -detected antibody to cytotoxin (ELISA cytotoxin 
antibody) during the period from day 0 to 21 (Figure 16). During the 
same period, the bacterin group had an insignificant increase in 
cytotoxin antibody response, whereas the ELISA cytotoxin antibody 
response for the PBS group remained relatively constant. From day 7 to 
21, a significant difference was seen between the responses of the 
live-vaccinates compared to both the bacterin and PBS groups. No 
significant difference was present between bacterin and PBS groups on 
any day. 
The means and standard deviations for ELISA cytotoxin antibody 
responses, cytotoxin neutralizing titers, FIAX titers, and lesion 
scores for each vaccine group are given in Table III. Analysis of 
Figure 14 Serum Cytotoxin Antibody ELISA - Serum Dilution Response. 
Each line represents doubling dilutions of different 
bovine sera tested in the ELISA. 
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Figure 15 Serum Cytotoxin Antibody ELISA - Antigen Specificity. 
Increasing concentrations of cytotoxin and capsular 
extract and increasing numbers of formalized bacteria 
were absorbed with sera containing anticytotoxin anti-
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Figure 16 Serum Cytotoxin Antibody ELISA - Vaccination Response. 
Live received live P. haemolytica subcutaneously, 
bacterin received formalin-killed P. haemolytica 
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TABLE III 
EFFECT OF VACCINATION ON SEROLOGIC PARAMETERS AND LESION SCORES 
PBS Bacterin Live 
Vaccinates Vaccinates Vaccinates 
Mean S.D. Mean S.D. Mean S.D. 
ELISA (A490) 0.39 0.18 0.30 0. 10 0.70 0.22 
Cytotoxin 
neutralization 6.4 5 • 1 8. 5 5. 2 88.0 36.4 
titer 
FlAX titer 28.5 15. 1 102.7 88. 1 17 3. 2 46.7 
Lesion score 16. 9 4.5 10.3 5.4 3. 7 2. 5 
"' ...... 
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variance between these three groups showed a significant difference (p 
< 0.0001) between the means regardless of which of the four parameters 
was used as the dependent variable. The results of least significant 
difference analysis between groups for each parameter indicated that 
ELISA cytotoxin antibody responses and cytotoxin neutralizing titers 
for live vaccinates were signficantly different (p < 0.05) from both 
the bacterin and PBS groups. Significant differences were not detected 
between bacterin and PBS vaccinated mean responses. For FlAX titers 
and lesion scores, a significant difference (p < 0.05) was present 
between the means of all three groups. 
Correlation coefficients (r) and probabilities (p) for all samples 
organized by parameter are given in Table IV. Directly measured values 
were used for comparisons of all parameters except the cytotoxin 
neutralization titer, which was transformed to the logarithm of the 
actual value. Correlation of ELISA cytotoxin antibody responses with 
cytotoxin neutralization, FlAX, and lesion score values were all 
significant at p<O.Ol. The strongest correlation was between ELISA 
cytotoxin antibody response and cytotoxin neutralization titers, 
whereas the lowest was between ELISA cytotoxin antibody response and 
FlAX titers. As an indicator of resistance to pneumonic pasteurellosis 
the ELISA had a better correlation with lesion score than did the FlAX. 
Significant correlations were not obtained between any parameters when 
samples were evaluated within individual vaccine groups. 
Discussion 
The result of this study was the development of a primary binding 


































bovine sera for antibody to ~ haemolytica cytotoxin. Previously 
reported ELISA's to ~ haemolytica have used either sodium salicylate 
extracts (Burrells et al., 1979; Donachie et al., 1983), or saline 
extracts (Confer et al., 1985) of ~ haemolytica as antigens. The 
current report is the first direct binding assay utilizing a purified 
cytotoxic ~ haemolytica antigen. The ELISA results provide similar 
information to that obtained by cytotoxin neutralization and 
eliminates the need for serial dilutions of sera, preparation of living 
cells, and use of radioisotopes. 
Preadsorption studies using various ~ haemolytica antigens 
demonstrated the specificity of the ELISA reaction for cytotoxin. When 
preincubated with high concentrations of cytotoxin, immunoglobulin 
antigen binding sites specific for cytotoxin apparently became 
saturated, resulting in large decreases in ELISA absorbance. Similar 
high concentrations of saline extracts of ~ haemolytica and formalin-
killed ~ haemolytica had only minor effects on absorbance. These 
results suggest that cytotoxin is not associated with structural 
components of the bacteria and further supports its classification as a 
true exotoxin (Shewen and Wilkie, 1985). 
Evaluation of the sera of feedlot cattle for the ability to 
neutralize ~ haemolytica cytotoxin demonstrated a signifiantly lower 
cytotoxin neutralizing activity in the serum of cattle which died of 
fibrinous pneumonia than in the sera of cattle which died for other 
reasons (Shewen and Wilkie, 1983). Similar associations between 
pneumonia and cytotoxin neutralization were found in studies of 
experimentally induced disease (Cho et al., 1984; Gentry et al., 
1985). A direct positive correlation was demonstrated between 
95 
resistance to experimental challenge with .!::._ haemolytica and serum 
cytotoxin neutralizing titers (Gentry et al., 1985). Antibodies to 
somatic antigens of .!::._ haemolytica as determined by a modified indirect 
complement fixation test, however, appeared to be unrelated to the 
development of pneumonia (Cho et al., 1984). 
The results of the current study supports these findings and 
suggest that exposure to live organisms is necessary to produce an 
immune response to cytotoxin and that this response is a better 
predictor of resistance to pneumonia than immune response to somatic 
antigens. ELISA cytotoxin antibody responses and cytotoxin 
neutralization titers for live-vaccinates were both significantly 
higher than those values for the· bacterin group. In association with 
this, mean lesion scores for the live vaccinates were significantly 
smaller than scores obtained with controls or the group receiving a 
bacterin. 
The relationship between the antigens of ~ haemolytica and 
resistance to disease is becoming more clearly defined. Bacterins 
stimulate a somatic antibody response which does not consistently 
provide protection from disease, and in some cases has been 
incriminated as enhancing disease (Friend et al., 1977; Wilkie et al, 
1980). In the current study, there was a significant reduction in the 
lesion scores of bacterin vaccinated animals compared to controls, 
however, indicating that some degree of protection was afforded by 
antibodies to somatic antigens. Animals which received live vaccine 
and possessed high levels of ELISA and cytotoxin neutralizing 
antibodies had lesion scores which were significantly lower than the 
bacterin group. Although additional protection was associated with 
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increased levels of cytotoxin antibodies, occasional animals with good 
neutralizing titers or ELISA antibody responses still developed severe 
pneumonic lesions. The reasons or factors involved in these cases are 
unknown. 
The etiology and pathogenesis of pneumonic pasteurellosis are 
complex and multifactorial. A successful product for immunologic 
prevention of the disease will most likely have to take into account 
multiple antigenic features of infectious agents associated with the 
disease. The ELISA described in this report provides a helpful tool 
for more clearly defining the role played by cytotoxin in pneumonic 
pasteurellosis. 
CHAPTER IV 
SUMMARY AND CONCLUSIONS 
The purpose of this study was to develop a procedure for the 
purification of Pasteurella haemolytica cytotoxin. Once obtained, 
purified cytotoxin was partially characterized biochemically and 
biologically. It was then used in immunologic studies to examine the 
role cytotoxin plays 1n the humoral response of the bovine to 
experimental pneumonic pasteurellosis. 
The purification procedure which was developed consisted of a 
series of three common chromatographic techniques (anion exchange, gel 
filtration, and chromatofocusing). The procedure was straightforward, 
reproducible, and yeilded large quantities of relatively pure 
cytotoxin. Native cytotoxin was found to be a 160 dKa protein. Upon 
denaturation, this protein was reduced into four predominate protein 
bands. Bands at 160 kDa and 23 kDa were non-antigenic 1n the bovine, 
whereas bands at 57 kDa and 66 kDa proved to be antigenic as determined 
with immunoblots utilizing bovine anticytotoxin immunoglobulin. Under 
certain conditions, an approximately 30 kDa protein which was cytotoxic 
but non-antigenic, T•7aS also encountered. 
Native cytotoxin was found to be biologically active through a 
pH range of 4.5-9.0. It was reversibly inactivated by high 10n1c 
strength and would undergo degradation with time. As well as being 
antigenic to the bovine, rabbits and m1ce also mounted antibody 
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responses against cytotoxin. 
An enzyme-linked immunosorbent assay (ELISA) was developed to 
measure the bovine serum antibody reponse to cytotoxin. This assay 
was shown to be highly specific for cytotoxic antigens and yeilded 
information similar to that obtained by cytotoxin neutralization 
assays. Cattle vaccinated witth live Pasteurella haemolytica had 
significantly higher ELISA cytotoxin antibody titers and less severe 
pneumonic lesions upon experimental challenge than those cattle 
vaccinated with P. haemolytica bacterins. ELISA cytotoxin antibody 
titers were more strongly correlated with experimental pneumonic lesions 
than were titers to somatic antigens of P. haemolytica. These results 
demonstrated the ELISA to cytotoxin to be a more accurate predictor 
of resistance to pneumonic pasteurellosis than tests measuring somatic 
antigens. 
The results of this study were three-fold. First, purification 
and characterization studies helped to more adequately define the nature 
of P. haemolytica cytotoxin. The purification procedure also allowed 
a. second accomplishment, which was the accumulation of adequate amounts 
of purified cytotoxin for use 1n future experiments. Third, 
immunological studies demonstrated the antigenicity of cytotoxin and 
the importance of a strong anticytotoxin antibody response for 
protection against experimental pneumonic pasteurellosis. 
Based upon the information obtained during this study, cytotoxin 
appears to be an important component involved in the pathogenesis of 
pneumonic pasteurellosis. Future studies should be directed towards 
additional purification of cytotoxin, development of techniques to yeild 
large amounts of both pruified cytotoxin and cytotoxin specific 
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antibodies for use in continued in vitro studies, and the use of 
cytotoxic antigens in in vivo vaccination trials. 
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APPENDIX 
INITIAL CHARACTERIZATION OF CYTOTOXIN 
Figure 17 Anion Exchange Chromatography of Crude Cytotoxin: Slcr 
release; Antigenicity. Absorbance profile (A), 51cr 




AMON EXCHANGE CHROMATOGRAPHY 






l [~! ~~ 
"---------""'-- 0 i 
• 10 XIO uo ,.a 1't0 --




., aoo~ w .... 













Figure 18 Cation Exchange Chromatography of Anion Fractions 15-45: 
51cr release; Antigenicity. Absorbance profile (A), 5lcr 
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Figure 19 Gel Filtration Chromatography of Cation Fractions 1-35: 
51cr release; Antigenicity. Absorbance profile (A), Slcr 
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Figure 20 Gel Filtration Chromatography. of Anion Fractions 50-80: 
Slcr release; Antigenicity. Absorbance profile (A), 51cr 
release profile (B), and antigenicity (ELISA) profile (C). 
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Figure 21 Gel Filtration Chromatography of Anion Fractions 95-12gi 
5lcr release; Antigenicity. Absorbance profile (A), Cr 
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Figure 22 Gel Filtration Chromatography of Anion Fractions 135-180: 
51cr release; Antigenicity. Absorbance profile (A), 5lcr 
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Figure 23 Gel Filtration Chromatography of Anion Fractions 185-205: 
5lcr release; Antigenicity. Absorbance profile (A), 5lcr 
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Figure 24 Gel Filtration Chromatography of Anion Fractions 215-235: 
51Cr release; Antigenicityo Absorbance profile (A), 51cr 
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Figure 25 Chromatofocusing of Fractions 35-70 obtained from Gel 
Filtration of Anion Fractions 135-180: Slcr release. 
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